- João Pedro Ferreira; Francisco Vasques-Nóvoa; João Sérgio Neves; Faiez Zannad; Adelino Leite-Moreira. "Comparison of interleukin-6
and high-sensitivity C-reactive protein for cardiovascular risk assessment: Findings from the MESA study". Atherosclerosis
(2024): https://doi.org/10.1016/j.atherosclerosis.2024.117461.
10.1016/j.atherosclerosis.2024.117461
- João Pedro Ferreira; João Sérgio Neves. "Response to Letter to Editor From Banerjee et al: “Glucagon-Like Peptide-1 Receptor
Agonists Across the Spectrum of Heart Failure”". The Journal of Clinical Endocrinology & Metabolism (2024): https://doi.org/10.1210/clinem/dgad507.
10.1210/clinem/dgad507
- Nitish K. Dhingra; Subodh Verma; Javed Butler; Stefan D. Anker; Joao Pedro Ferreira; Gerasimos Filippatos; James L. Januzzi;
et al. "Efficacy and Safety of Empagliflozin According to Background Diuretic Use in HFrEF". JACC: Heart Failure (2024):
https://doi.org/10.1016/j.jchf.2023.06.036.
10.1016/j.jchf.2023.06.036
- Ferreira JP; Claggett BL; Liu J; Sharma A; Desai AS; Anand IS; O'Meara E; et al. "High-sensitivity C-reactive protein in heart
failure with preserved ejection fraction: Findings from TOPCAT.". International journal of cardiology (2024): http://europepmc.org/abstract/med/38307421.
10.1016/j.ijcard.2024.131818
- Rastogi T; Ferreira JP; Butler J; Kraus BJ; Mattheus M; Brueckmann M; Filippatos G; et al. "Early changes in estimated glomerular
filtration rate post-initiation of empagliflozin in EMPEROR-Preserved.". European journal of heart failure (2024):
http://europepmc.org/abstract/med/38247160.
10.1002/ejhf.3136
- João Pedro Ferreira; Javed Butler; Stefan D. Anker; James L. Januzzi; Marina Panova-Noeva; Alexander L. Reese-Petersen; Naveed
Sattar; et al. "Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR
trials". European Journal of Heart Failure (2023): https://doi.org/10.1002/ejhf.3101.
10.1002/ejhf.3101
- João Pedro Ferreira; Abhinav Sharma; Javed Butler; Milton Packer; Faiez Zannad; Francisco Vasques-Nóvoa; Adelino Leite-Moreira;
João Sérgio Neves. "Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure". The Journal of Clinical
Endocrinology & Metabolism (2023): https://doi.org/10.1210/clinem/dgad398.
10.1210/clinem/dgad398
- JOÃO PEDRO FERREIRA; JOÃO SÉRGIO NEVES; FRANCISCA SARAIVA. "Cardiovascular Prevention in Obese Patients Without Diabetes:
Risk-based Strategies Are Needed". Journal of Cardiac Failure (2023): https://doi.org/10.1016/j.cardfail.2023.12.002.
10.1016/j.cardfail.2023.12.002
- João Pedro Ferreira; Tiago Taveira-Gomes; Mariana Canelas-Pais; Phillip Phan; Filipa Bernardo; Karolina Andersson Sundell;
Mário Almeida; Hugo Martinho; Cristina Gavina. "Missed opportunities in the diagnosis of heart failure: a real-world assessment".
ESC Heart Failure (2023): https://doi.org/10.1002/ehf2.14531.
10.1002/ehf2.14531
- Monzo L; Girerd N; Ferreira JP; Lamiral Z; Anker SD; Cleland JGF; Kondo T; et al. "High Risk of Stroke in Patients With Worsening
Heart Failure, Reduced Ejection Fraction, Coronary Heart Disease and Sinus Rhythm: Risk Prediction Score Analysis From the
COMMANDER-HF Trial.". Journal of cardiac failure (2023): http://europepmc.org/abstract/med/38122924.
10.1016/j.cardfail.2023.11.020
- Coats AJS; Butler J; Tsutsui H; Doehner W; Filippatos G; Ferreira JP; Böhm M; et al. "Efficacy of empagliflozin in heart failure
with preserved ejection fraction according to frailty status in EMPEROR-Preserved.". Journal of cachexia, sarcopenia and
muscle (2023): http://europepmc.org/abstract/med/38158636.
10.1002/jcsm.13393
- Baudry G; Pereira O; Duarte K; Ferreira JP; Savarese G; Welter A; Tangre P; et al. "Risk of readmission and death after hospitalization
for worsening heart failure: Role of post-discharge follow-up visits in a real-world study from the Grand Est Region of France.".
European journal of heart failure (2023): http://europepmc.org/abstract/med/38059342.
10.1002/ejhf.3103
- João Pedro Ferreira; Milton Packer; Javed Butler; Gerasimos Filippatos; Stuart J. Pocock; James L. Januzzi; Naveed Sattar;
et al. "Growth differentiation factor-15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program".
European Journal of Heart Failure (2023): https://doi.org/10.1002/ejhf.3078.
10.1002/ejhf.3078
- Ferreira JP; Rossello X; Zannad F. "Mineralocorticoid receptor antagonist indication and underuse in high-risk post-myocardial
infarction patients.". European journal of heart failure (2023): http://europepmc.org/abstract/med/38013392.
10.1002/ejhf.3098
- Razaghizad A; Aziz H; Zhang GK; Ferreira JP; White WB; Mehta CR; Bakris GL; Zannad F; Sharma A. "Pathophysiological Sex Differences
in Heart Failure Progression After Acute Coronary Syndrome: Insights From the EXAMINE Trial.". Journal of cardiac failure
(2023): http://europepmc.org/abstract/med/37939897.
10.1016/j.cardfail.2023.10.474
- Rivas-Lasarte M; Ferreira JP. "Heart Failure in Brazil and the Need to Measure and Take Action.". Journal of cardiac failure
(2023): http://europepmc.org/abstract/med/38016621.
10.1016/j.cardfail.2023.10.485
- Santos-Ferreira D; Diaz SO; Ferreira JP; Girerd N; Pellicori P; Mariottoni B; Cosmi F; et al. "Phenotyping patients with ischaemic
heart disease at risk of developing heart failure: an analysis of the HOMAGE trial.". ESC heart failure (2023): http://europepmc.org/abstract/med/37939716.
10.1002/ehf2.14465
- João Pedro Ferreira; Jonathan P. Blatchford; John R. Teerlink; Mikhail N. Kosiborod; Christiane E. Angermann; Jan Biegus;
Sean P. Collins; et al. "Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in
patients admitted for acute heart failure: Findings from EMPULSE". European Journal of Heart Failure (2023): https://doi.org/10.1002/ejhf.2982.
10.1002/ejhf.2982
- Milton Packer; Javed Butler; Cordula Zeller; Stuart J. Pocock; Martina Brueckmann; João Pedro Ferreira; Gerasimos Filippatos;
et al. "Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure".
Circulation (2023): https://doi.org/10.1161/CIRCULATIONAHA.123.065748.
10.1161/CIRCULATIONAHA.123.065748
- Schmidt C; Magalhães S; Gois Basilio P; Gouveia M; Teixeira M; Santos C; Tavares AI; et al. "Home- versus centre-based EXercise
InTervention in patients with Heart Failure (EXIT-HF trial): A pragmatic randomized controlled trial.". Revista portuguesa
de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal
of the Portuguese Society of Cardiology (2023): http://europepmc.org/abstract/med/37716466.
10.1016/j.repc.2023.05.013
- Cardoso JS; Santos J; Araújo I; Andrade A; Sarmento PM; Santos P; Moura B; et al. "conTemporary reflectiOns regarding heart
Failure manaGEmenT - How to ovERcome the PorTuguese barriers (TOGETHER-PT).". Revista portuguesa de cardiologia : orgao
oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese
Society of Cardiology (2023): http://europepmc.org/abstract/med/37689388.
10.1016/j.repc.2023.05.012
- Mendonça LCF; Vieira MB; Sérgio Neves J; Castro Chaves P; Ferreira JP. "A 4-variable model to predict cardio-kidney events
and mortality in chronic kidney disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.". American journal of nephrology
(2023): http://europepmc.org/abstract/med/37673057.
10.1159/000533223
- Neves JS; Borges-Canha M; Vasques-Nóvoa F; Green JB; Leiter LA; Granger CB; Carvalho D; et al. "GLP-1 Receptor Agonist Therapy
With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes.". Journal of the American College of Cardiology
(2023): http://europepmc.org/abstract/med/37532422.
10.1016/j.jacc.2023.05.048
- Monzo L; Huttin O; Ferreira JP; Lamiral Z; Bozec E; Beaumont M; Micard E; et al. "Role of aldosterone in mid- and long-term
left ventricular remodelling after acute myocardial infarction: The REMI study.". European journal of heart failure
(2023): http://europepmc.org/abstract/med/37530453.
10.1002/ejhf.2986
- Sharma A; Caldeira D; Razaghizad A; Pinto FJ; van Veldhuisen DJ; Mehra MR; Lam CSP; et al. "Cardiovascular effects of rivaroxaban
in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international
cohort study from COMMANDER-HF.". BMJ open (2023): http://europepmc.org/abstract/med/37567750.
10.1136/bmjopen-2022-068865
- Khan MS; Anker SD; Filippatos G; Ferreira JP; Pocock SJ; Januzzi JL; Chopra VK; et al. "Vascular Disease Burden, Outcomes
and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial.". Journal of cardiac failure
(2023): http://europepmc.org/abstract/med/37558088.
10.1016/j.cardfail.2023.06.024
- Marques P; Matias P; Packer M; Vieira JT; Vasques-Nóvoa F; Sharma A; Mavrakanas TA; Friões F; Ferreira JP. "Erythropoietic
response after intravenous iron in patients with heart failure and reduced ejection fraction with and without background treatment
with sodium-glucose cotransporter 2 inhibitors.". European journal of heart failure (2023): http://europepmc.org/abstract/med/37559543.
10.1002/ejhf.2992
- Monzo L; Girerd N; Duarte K; Ferreira JP; McMurray JJV; van Veldhuisen DJ; Swedberg K; et al. "Time to clinical benefit of
eplerenone among patients with heart failure and reduced ejection fraction: A subgroups analysis from the EMPHASIS-HF trial.".
European journal of heart failure (2023): http://europepmc.org/abstract/med/37370197.
10.1002/ejhf.2952
- Brandão M; Fonseca T; Quelhas Costa R; Oliveira JC; Cyrne Carvalho H; Rodrigues P; Zannad F; et al. "Impact of disease duration
on proteomic bioprofile and prognosis in rheumatoid arthritis patients.". Clinical and experimental rheumatology (2023):
http://europepmc.org/abstract/med/37470226.
10.55563/clinexprheumatol/ua087b
- Butler J; Usman MS; Filippatos G; Ferreira JP; Böhm M; Brueckmann M; Januzzi JL; et al. "Safety and Efficacy of Empagliflozin
and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved
Trial.". JAMA cardiology (2023): http://europepmc.org/abstract/med/37223933.
10.1001/jamacardio.2023.1090
- Marli Cruz; João Pedro Ferreira; Silvia O. Diaz; Diana Ferrão; Ana Isabel Ferreira; Nicolas Girerd; Francisco Sampaio; Joana
Pimenta. "Lung ultrasound and diuretic therapy in chronic heart failure: a randomised trial". Clinical Research in Cardiology
(2023): https://doi.org/10.1007/s00392-023-02238-9.
10.1007/s00392-023-02238-9
- João Pedro Ferreira; Faiez Zannad; Javed Butler; Gerasimos Filippatos; Stuart Pocock; Tomoko Iwata; Mikhail Sumin; et al.
"Recency of Heart Failure Hospitalization, Outcomes, and the Effect of Empagliflozin". JACC: Heart Failure (2023):
https://doi.org/10.1016/j.jchf.2023.01.018.
10.1016/j.jchf.2023.01.018
- João Pedro Ferreira; Francisca Saraiva; Abhinav Sharma; Francisco Vasques-Nóvoa; António Angélico-Gonçalves; Ana Rita Leite;
Marta Borges-Canha; et al. "Glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic
heart failure: A meta-analysis of randomized placebo-controlled outcome trials". Diabetes, Obesity and Metabolism (2023):
https://doi.org/10.1111/dom.14997.
10.1111/dom.14997
- Leite AR; Neves JS; Angélico-Gonçalves A; Vasques-Nóvoa F; Saraiva FA; Pinho IB; Oliveira AC; et al. "Clinical and Pathophysiologic
Insights of Free triiodothyronine/Free thyroxine Ratio in Patients with Heart Failure with Preserved Ejection Fraction: Data
from the NETDiamond Cohort.". Cardiology (2023): http://europepmc.org/abstract/med/37285810.
10.1159/000530136
- Böhm M; Butler J; Krawczyk M; Mahfoud F; Haring B; Filippatos G; Ferreira JP; et al. "Liver tests, cardiovascular outcomes
and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trial.".
European journal of heart failure (2023): http://europepmc.org/abstract/med/37278451.
10.1002/ejhf.2922
- Schrage B; Lund LH; Benson L; Braunschweig F; Ferreira JP; Dahlström U; Metra M; Rosano GMC; Savarese G. "Association between
a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: An analysis from
the Swedish Heart Failure Registry.". European journal of heart failure (2023): http://europepmc.org/abstract/med/37317585.
10.1002/ejhf.2928
- Nicolas Girerd; Daniel Levy; Kevin Duarte; Joao Pedro Ferreira; Christie Ballantyne; Timothy Collier; Anne Pizard; et al.
"Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk
in Communities Study, and the Framingham Heart Study". Circulation: Heart Failure (2023): https://doi.org/10.1161/CIRCHEARTFAILURE.122.009694.
10.1161/CIRCHEARTFAILURE.122.009694
- Stuart J. Pocock; João Pedro Ferreira; Timothy J. Collier; Christiane E. Angermann; Jan Biegus; Sean P. Collins; Mikhail Kosiborod;
et al. "The win ratio method in heart failure trials: lessons learnt from EMPULSE". European Journal of Heart Failure
(2023): https://doi.org/10.1002/ejhf.2853.
10.1002/ejhf.2853
- Angélico-Gonçalves A; Leite AR; Neves JS; Saraiva F; Brochado L; Oliveira AC; Butler J; et al. "Changes in health-related
quality of life and treatment effects in chronic heart failure: a meta-analysis.". International journal of cardiology
(2023): http://europepmc.org/abstract/med/37211049.
10.1016/j.ijcard.2023.05.032
- Butler J; Packer M; Siddiqi TJ; Böhm M; Brueckmann M; Januzzi JL; Verma S; et al. "Efficacy of Empagliflozin in Patients With Heart Failure
Across Kidney Risk Categories.". Journal of the American College of Cardiology (2023): http://europepmc.org/abstract/med/37164523.
10.1016/j.jacc.2023.03.390
- Verma S; Dhingra NK; Bonaca MP; Butler J; Anker SD; Ferreira JP; Filippatos G; et al. "Presence of Peripheral Artery Disease
Is Associated With Increased Risk of Heart Failure Events: Insights From EMPEROR-Pooled.". Arteriosclerosis, thrombosis,
and vascular biology (2023): http://europepmc.org/abstract/med/37199158.
10.1161/atvbaha.123.319156
- Filippatos G; Farmakis D; Butler J; Zannad F; Ferreira JP; Ofstad AP; Iwata T; et al. "Empagliflozin in heart failure with
preserved ejection fraction with and without atrial fibrillation.". European journal of heart failure (2023): http://europepmc.org/abstract/med/37062866.
10.1002/ejhf.2861
- Sharma A; Ferreira JP; Zannad F; Pocock SJ; Filippatos G; Pfarr E; Petrini M; et al. "Cardiac and kidney benefits of empagliflozin
in heart failure across the spectrum of kidney function: insights from the EMPEROR-Preserved trial.". European journal
of heart failure (2023): http://europepmc.org/abstract/med/37062851.
10.1002/ejhf.2857
- Kobayashi M; Huttin O; Ferreira JP; Duarte K; González A; Heymans S; Verdonschot JAJ; et al. "A machine learning derived echocardiographic
algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone:
findings from the HOMAGE trial.". European journal of heart failure (2023): http://europepmc.org/abstract/med/37062878.
10.1002/ejhf.2859
- Ferreira MB; Kobayashi M; Costa RQ; Fonseca T; Brandão M; Oliveira JC; Marinho A; et al. "Unsupervised clustering to differentiate
rheumatoid arthritis patients based on proteomic signatures.". Scandinavian journal of rheumatology (2023): http://europepmc.org/abstract/med/37083270.
10.1080/03009742.2023.2196781
- Dewan P; Ferreira JP; Butt JH; Petrie MC; Abraham WT; Desai AS; Dickstein K; et al. "Impact of multimorbidity on mortality
in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM-HF and ATMOSPHERE.".
European journal of heart failure (2023): http://europepmc.org/abstract/med/37062869.
10.1002/ejhf.2856
- Butler J; Siddiqi TJ; Zannad F; Ferreira JP; Fillipatos G; Anker SD; Packer M. "Interaction of natriuretic peptide levels
and ejection fraction on outcomes with dapagliflozin and empagliflozin in heart failure.". European journal of heart failure
(2023): http://europepmc.org/abstract/med/37038319.
10.1002/ejhf.2854
- Ferreira JP; Zannad F; Kiernan MS; Konstam MA. "High- versus low-dose losartan and uric acid: An analysis from HEAAL.". Journal
of cardiology (2023): http://europepmc.org/abstract/med/37030532.
10.1016/j.jjcc.2023.04.005
- Neves JS; Packer M; Ferreira JP. "Increased risk of heart failure hospitalization with GLP-1 receptor agonists in patients
with reduced ejection fraction: a meta-analysis of the EXSCEL and FIGHT trials.". Journal of cardiac failure (2023):
http://europepmc.org/abstract/med/37028749.
10.1016/j.cardfail.2023.03.017
- Peter Carson; John R. Teerlink; Michel Komajda; Inder Anand; Stefan D. Anker; Javed Butler; Wolfram Doehner; et al. "Comparison
of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial". JACC: Heart Failure
(2023): https://doi.org/10.1016/j.jchf.2022.11.017.
10.1016/j.jchf.2022.11.017
- Siddiqi TJ; Anker SD; Filippatos G; Ferreira JP; Pocock SJ; Böhm M; Brueckmann M; et al. "Health status across major subgroups
of patients with heart failure and preserved ejection fraction.". European journal of heart failure (2023): http://europepmc.org/abstract/med/36974746.
10.1002/ejhf.2831
- João Pedro Ferreira; John G.F. Cleland; Nicolas Girerd; Pierpaolo Pellicori; Mark R. Hazebroek; Job Verdonschot; Timothy J.
Collier; et al. "Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial)".
The American Journal of Cardiology (2023): https://doi.org/10.1016/j.amjcard.2022.12.016.
10.1016/j.amjcard.2022.12.016
- João Pedro Ferreira; Adelino Leite-Moreira; Altamiro Da Costa-Pereira; António José Soares; Carlos Robalo-Cordeiro; Cármen
Jerónimo; Cristina Gavina; et al. "Investigação Clínica da Iniciativa do Investigador em Portugal: Identificação de Problemas
e Propostas para Melhoria". Acta Médica Portuguesa (2023): https://doi.org/10.20344/amp.19333.
10.20344/amp.19333
- Michael Böhm; Stefan Anker; Felix Mahfoud; Lucas Lauder; Gerasimos Filippatos; João Pedro Ferreira; Stuart J Pocock; et al.
"Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved
trial". European Heart Journal (2023): https://doi.org/10.1093/eurheartj/ehac693.
10.1093/eurheartj/ehac693
- Ferreira JP; Cleland JG; Girerd N; Rossignol P; Pellicori P; Cosmi F; Mariottoni B; et al. "Spironolactone effect on circulating
procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials.". International journal of
cardiology (2023): http://europepmc.org/abstract/med/36738846.
10.1016/j.ijcard.2023.01.088
- Marques P; Brito MT; Vasques-Nóvoa F; Ferreira JP; Jardim AL; Gouveia R; Besteiro B; et al. "Door-to-furosemide time and clinical
outcomes in acute heart failure.". European journal of emergency medicine : official journal of the European Society for
Emergency Medicine (2023): http://europepmc.org/abstract/med/36735452.
10.1097/mej.0000000000001006
- João Pedro Ferreira; John G. F. Cleland; Nicolas Girerd; Pierpaolo Pellicori; Mark R. Hazebroek; Job Verdonschot; Timothy
J. Collier; et al. "Early and late renal function changes with spironolactone in patients at risk of developing heart failure:
findings from the HOMAGE trial". Clinical Research in Cardiology (2023): https://doi.org/10.1007/s00392-022-02116-w.
10.1007/s00392-022-02116-w
- Muhammad Shahzeb Khan; Javed Butler; Stefan D. Anker; Gerasimos Filippatos; João Pedro Ferreira; Stuart J. Pocock; James L.
Januzzi; et al. "Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus
Nonischemic Cause". Journal of the American Heart Association (2023): https://doi.org/10.1161/JAHA.122.027652.
10.1161/JAHA.122.027652
- Subodh Verma; Nitish K. Dhingra; Javed Butler; Stefan D. Anker; João Pedro Ferreira; Gerasimos Filippatos; James L. Januzzi;
et al. "Empagliflozin in Black Versus White Patients With Heart Failure: Analysis of EMPEROR-Pooled". Circulation (2023):
https://doi.org/10.1161/CIRCULATIONAHA.122.062644.
10.1161/CIRCULATIONAHA.122.062644
- Amir Razaghizad; Abhinav Sharma; Jiayi Ni; João Pedro Ferreira; William B. White; Cyrus R. Mehta; George L. Bakris; Faiez
Zannad. "External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute
coronary syndrome: An analysis of the EXAMINE trial". Diabetes, Obesity and Metabolism (2023): https://doi.org/10.1111/dom.14867.
10.1111/dom.14867
- João Pedro Ferreira; John G. Cleland; Nicolas Girerd; Erwan Bozec; Patrick Rossignol; Pierpaolo Pellicori; Franco Cosmi; et
al. "Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction:
a pooled analysis of three randomized trials". European Journal of Heart Failure (2023): https://doi.org/10.1002/ejhf.2726.
10.1002/ejhf.2726
- JOÃO PEDRO Ferreira; MARVIN KONSTAM; PATRICK ROSSIGNOL; MICHAEL S. KIERNAN; FAIEZ ZANNAD. "High- Versus Low-dose Losartan
and Serum Potassium: An Analysis From HEAAL". Journal of Cardiac Failure (2023): https://doi.org/10.1016/j.cardfail.2022.09.008.
10.1016/j.cardfail.2022.09.008
- João Sérgio Neves; Francisco Vasques-Nóvoa; Marta Borges-Canha; Ana Rita Leite; Abhinav Sharma; Davide Carvalho; Milton Packer;
et al. "Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the
FIGHT trial". Diabetes, Obesity and Metabolism (2023): https://doi.org/10.1111/dom.14862.
10.1111/dom.14862
- Faiez Zannad; João Pedro Ferreira; Javed Butler; Gerasimos Filippatos; James L Januzzi; Mikhail Sumin; Matthias Zwick; et
al. "Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme".
European Heart Journal (2022): https://doi.org/10.1093/eurheartj/ehac495.
10.1093/eurheartj/ehac495
- Anker SD; Butler J; Usman MS; Filippatos G; Ferreira JP; Bocchi E; Böhm M; et al. "Efficacy of empagliflozin in heart failure
with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved.". Nature medicine
(2022): http://europepmc.org/abstract/med/36471037.
10.1038/s41591-022-02041-5
- Kobayashi M; Ferreira JP; Matsue Y; Chikamori T; Ito S; Asakura M; Yamashina A; Kitakaze M. "Effect of eplerenone on clinical
stability of Japanese patients with acute heart failure.". International journal of cardiology (2022): http://europepmc.org/abstract/med/36586516.
10.1016/j.ijcard.2022.12.045
- Anker SD; Khan MS; Butler J; Ofstad AP; Peil B; Pfarr E; Doehner W; et al. "Weight change and clinical outcomes in heart failure
with reduced ejection fraction: insights from EMPEROR-Reduced.". European journal of heart failure (2022): http://europepmc.org/abstract/med/36325584.
10.1002/ejhf.2728
- Ferreira MB; Saraiva FA; Fonseca T; Costa R; Marinho A; Oliveira JC; Carvalho HC; Rodrigues P; Ferreira JP. "Clinical associations
and prognostic implications of 6-minute walk test in rheumatoid arthritis.". Scientific reports (2022): http://europepmc.org/abstract/med/36333405.
10.1038/s41598-022-21547-z
- João Pedro Ferreira; João Sérgio Neves. "Letter regarding the article ‘Dulaglutide and cardiovascular and heart failure outcomes
in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial". European Journal of
Heart Failure (2022): https://doi.org/10.1002/ejhf.2694.
10.1002/ejhf.2694
- João Pedro Ferreira; Bertram Pitt; John J.V. McMurray; Stuart J. Pocock; Scott D. Solomon; Marc A. Pfeffer; Faiez Zannad;
Patrick Rossignol. "Steroidal MRA Across the Spectrum of Renal Function". JACC: Heart Failure (2022): https://doi.org/10.1016/j.jchf.2022.06.010.
10.1016/j.jchf.2022.06.010
- Javed Butler; Gerasimos Filippatos; Tariq Jamal Siddiqi; João Pedro Ferreira; Martina Brueckmann; Edimar Bocchi; Michael Böhm;
et al. "Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction". Circulation
(2022): https://doi.org/10.1161/CIRCULATIONAHA.122.059755.
10.1161/CIRCULATIONAHA.122.059755
- Wassim Bedrouni; Abhinav Sharma; Bertram Pitt; Carolyn S.P. Lam; Jiayi Ni; João Pedro Ferreira; John McMurray; et al. "Timing
of Statistical Benefit of Mineralocorticoid Receptor Antagonists Among Patients With Heart Failure and Post-Myocardial Infarction".
Circulation: Heart Failure (2022): https://doi.org/10.1161/CIRCHEARTFAILURE.121.009295.
10.1161/CIRCHEARTFAILURE.121.009295
- Biegus J; Voors AA; Collins SP; Kosiborod MN; Teerlink JR; Angermann CE; Tromp J; et al. "Impact of empagliflozin on decongestion
in acute heart failure: the EMPULSE trial.". European heart journal (2022): http://europepmc.org/abstract/med/36254693.
10.1093/eurheartj/ehac530
- Filippatos G; Anker SD; Butler J; Farmakis D; Ferreira JP; Gollop ND; Brueckmann M; et al. "Effects of empagliflozin on cardiovascular
and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR-Reduced.".
European journal of heart failure (2022): http://europepmc.org/abstract/med/36194680.
10.1002/ejhf.2707
- João Pedro Ferreira; Abhinav Sharma; Francisco Vasques-Nóvoa; António Angélico-Gonçalves; Ana Rita Leite; Marta Borges-Canha;
Davide Carvalho; et al. "Albiglutide in patients with type 2 diabetes and heart failure: a post-hoc analysis from Harmony
Outcomes". European Journal of Heart Failure (2022): https://doi.org/10.1002/ejhf.2660.
10.1002/ejhf.2660
- João Pedro Ferreira; João Sérgio Neves. "Glucagon-like peptide 1 receptor agonists in heart failure: the need for a rewind".
European Journal of Heart Failure (2022): https://doi.org/10.1002/ejhf.2693.
10.1002/ejhf.2693
- Stuart J. Pocock; João Pedro Ferreira; Milton Packer; Faiez Zannad; Gerasimos Filippatos; Toru Kondo; John J.V. McMurray;
et al. "Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR–Preserved
trial". European Journal of Heart Failure (2022): https://doi.org/10.1002/ejhf.2607.
10.1002/ejhf.2607
- Böhm M; Butler J; Mahfoud F; Filippatos G; Ferreira JP; Pocock SJ; Slawik J; et al. "Heart failure outcomes according to heart
rate and effects of empagliflozin in patients of the EMPEROR-Preserved trial.". European journal of heart failure (2022):
http://europepmc.org/abstract/med/36087309.
10.1002/ejhf.2677
- Ferreira JP; Zannad F; Butler J; Filippatos G; Pocock SJ; Brueckmann M; Steubl D; et al. "Association of Empagliflozin Treatment
With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled.". JAMA cardiology (2022):
http://europepmc.org/abstract/med/36129693.
10.1001/jamacardio.2022.2924
- Vasques-Nóvoa F; Pedro Ferreira J; Marques P; Sergio Neves J; Vale C; Ribeirinho-Soares P; Marques J; et al. "Interleukin-6,
infection and cardiovascular outcomes in acute heart failure: Findings from the EDIFICA registry.". Cytokine (2022):
http://europepmc.org/abstract/med/36179534.
10.1016/j.cyto.2022.156053
- Hardt K; Vandebosch A; Sadoff J; Le Gars M; Truyers C; Lowson D; Van Dromme I; et al. "Efficacy, safety, and immunogenicity
of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled,
phase 3 trial.". The Lancet. Infectious diseases (2022): http://europepmc.org/abstract/med/36113538.
10.1016/s1473-3099(22)00506-0
- Bresso E; Ferreira JP; Girerd N; Kobayashi M; Preud'homme G; Rossignol P; Zannad F; Devignes MD; Smaïl-Tabbone M. "Inductive
database to support iterative data mining: Application to biomarker analysis on patient data in the Fight-HF project.". Journal
of biomedical informatics (2022): http://europepmc.org/abstract/med/36182054.
10.1016/j.jbi.2022.104212
- Voors AA; Damman K; Teerlink JR; Angermann CE; Collins SP; Kosiborod M; Biegus J; et al. "Renal effects of empagliflozin in
patients hospitalized for acute heart failure: from the EMPULSE trial.". European journal of heart failure (2022):
http://europepmc.org/abstract/med/36066557.
10.1002/ejhf.2681
- Monzo L; Ferreira JP; Cleland JGF; Pellicori P; Mariottoni B; Hazebroek MR; Collier TJ; et al. "Dyskalemia in people at increased
risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial.". ESC heart failure (2022): http://europepmc.org/abstract/med/36065795.
10.1002/ehf2.14086
- João Pedro Ferreira; Faiez Zannad; Javed Butler; Gerasimos Filipattos; Ivana Ritter; Elke Schüler; Bettina J Kraus; et al.
"Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled". European Heart Journal (2022):
https://doi.org/10.1093/eurheartj/ehac306.
10.1093/eurheartj/ehac306
- Ana Rita Leite; António Angélico-Gonçalves; Francisco Vasques-Nóvoa; Marta Borges-Canha; Adelino Leite-Moreira; João Sérgio
Neves; João Pedro Ferreira. "Effect of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or
obese adults without diabetes: A meta-analysis of placebo-controlled randomized trials". Diabetes, Obesity and Metabolism
(2022): https://doi.org/10.1111/dom.14707.
10.1111/dom.14707
- João Pedro Ferreira; Ana Leite; António Gonçalves; Marta Canha; João Sérgio Neves. "Letter of reply to the letter by Ryan".
Diabetes, Obesity and Metabolism (2022): https://doi.org/10.1111/dom.14743.
10.1111/dom.14743
- Ferreira JP; Pimenta J; Moura B; Aguiar C; Franco F. "Use of sodium glucose co-transporter 2 inhibitors in acute heart failure:
a practical guidance.". ESC heart failure (2022): http://europepmc.org/abstract/med/36004699.
10.1002/ehf2.14090
- Vaduganathan M; Ferreira JP; Rossignol P; Neuen BL; Claggett BL; Pfeffer MA; McMurray JJV; et al. "Effects of steroidal mineralocorticoid
receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failure.".
European journal of heart failure (2022): http://europepmc.org/abstract/med/35867859.
10.1002/ejhf.2635
- Mikhail N. Kosiborod; Christiane E. Angermann; Sean P. Collins; John R. Teerlink; Piotr Ponikowski; Jan Biegus; Josep Comin-Colet;
et al. "Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute
Heart Failure: Results From the EMPULSE Trial". Circulation (2022): https://doi.org/10.1161/CIRCULATIONAHA.122.059725.
10.1161/CIRCULATIONAHA.122.059725
- João Pedro Ferreira; Francisco Vasques-Nóvoa; Diana Ferrão; Francisca Saraiva; Inês Falcão-Pires; João Sérgio Neves; Abhinav
Sharma; et al. "Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD". Diabetes
Care (2022): https://doi.org/10.2337/dc21-1977.
10.2337/dc21-1977
- Doehner W; Anker SD; Butler J; Zannad F; Filippatos G; Ferreira JP; Salsali A; et al. "Uric acid and sodium-glucose cotransporter-2
inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.". European heart
journal (2022): http://europepmc.org/abstract/med/35788657.
10.1093/eurheartj/ehac320
- Michael Böhm; Javed Butler; Gerasimos Filippatos; João Pedro Ferreira; Stuart J. Pocock; Amr Abdin; Felix Mahfoud; et al.
"Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age". Journal
of the American College of Cardiology 80 1 (2022): 1-18. https://doi.org/10.1016/j.jacc.2022.04.040.
10.1016/j.jacc.2022.04.040
- Ferreira JP; Claggett BL; Docherty KF; Jhund PS; Zannad F; Solomon SD; McMurray JJV. "Within trial comparison of survival
time projections from short-term follow-up with long-term follow-up findings.". ESC heart failure (2022): http://europepmc.org/abstract/med/35799450.
10.1002/ehf2.13731
- Pintalhão M; Vasques-Nóvoa F; Couto-Viana B; Pimentel MJ; Neves JS; Mendonça L; Saraiva F; et al. "Relaxin-2, pathophysiological
insights and outcomes in heart failure with preserved ejection fraction: Findings from the NETDiamond cohort.". International
journal of cardiology (2022): http://europepmc.org/abstract/med/35870634.
10.1016/j.ijcard.2022.07.037
- Kobayashi M; Girerd N; Ferreira JP; Kevin D; Huttin O; González A; Bozec E; et al. "The association between markers of type
I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from
the HOMAGE trial.". European journal of heart failure (2022): http://europepmc.org/abstract/med/35703355.
10.1002/ejhf.2579
- Zannad F; Ferreira JP; Gregson J; Kraus BJ; Mattheus M; Hauske SJ; Butler J; et al. "Early changes in estimated glomerular
filtration rate post-initiation of empagliflozin in EMPEROR-Reduced.". European journal of heart failure (2022): http://europepmc.org/abstract/med/35711093.
10.1002/ejhf.2578
- Filippatos G; Butler J; Farmakis D; Zannad F; Pernille Ofstad A; Pedro Ferreira J; Green JB; et al. "Empagliflozin for Heart
Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes.". Circulation (2022): http://europepmc.org/abstract/med/35762322.
10.1161/circulationaha.122.059785
- Markousis-Mavrogenis G; Tromp J; Ouwerkerk W; Ferreira JP; Anker SD; Cleland JG; Dickstein K; et al. "Multimarker profiling
identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF.". Cardiovascular research
(2022): http://europepmc.org/abstract/med/34264317.
10.1093/cvr/cvab235
- Januzzi JL; Butler J; Zannad F; Filippatos G; Ferreira JP; Pocock SJ; Sattar N; et al. "Prognostic Implications of N-Terminal
Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved.". JACC. Heart failure
(2022): http://europepmc.org/abstract/med/35670067.
10.1016/j.jchf.2022.05.004
- Amir Razaghizad; Emily Oulousian; Varinder Kaur Randhawa; João Pedro Ferreira; James M. Brophy; Stephen J. Greene; Julian
Guida; et al. "Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta-Analysis".
Journal of the American Heart Association (2022): https://doi.org/10.1161/JAHA.121.024833.
10.1161/JAHA.121.024833
- Mehmet Kanbay; Constance Xhaard; Edith Le Floch; Claire Dandine-Roulland; Nicolas Girerd; João Pedro Ferreira; Jean-Marc Boivin;
et al. "Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study
Cohort With a 20-Year Follow-Up". Journal of the American Heart Association (2022): https://doi.org/10.1161/JAHA.121.023301.
10.1161/JAHA.121.023301
- Anker SD; Siddiqi TJ; Filippatos G; Zannad F; Ferreira JP; Pocock SJ; Brueckmann M; et al. "Outcomes with empagliflozin in
heart failure with preserved ejection fraction using DELIVER-like endpoint definitions.". European journal of heart failure
(2022): http://europepmc.org/abstract/med/35604680.
10.1002/ejhf.2558
- Albert Henry; María Gordillo-Marañón; Chris Finan; Amand F. Schmidt; João Pedro Ferreira; Ravi Karra; Johan Sundström; et
al. "Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization". Circulation 145
16 (2022): 1205-1217. https://doi.org/10.1161/CIRCULATIONAHA.121.056663.
10.1161/CIRCULATIONAHA.121.056663
- Tripti Rastogi; Nicolas Girerd; Zohra Lamiral; Emmanuel Bresso; Erwan Bozec; Jean-Marc Boivin; Patrick Rossignol; Faiez Zannad;
João Pedro Ferreira. "Impact of smoking on cardiovascular risk and premature ageing: Findings from the STANISLAS cohort".
Atherosclerosis 346 (2022): 1-9. https://doi.org/10.1016/j.atherosclerosis.2022.02.017.
10.1016/j.atherosclerosis.2022.02.017
- Ferreira MB; Fonseca T; Costa R; Marinho A; Oliveira JC; Zannad F; Rossignol P; et al. "Sex differences in circulating proteins
of patients with rheumatoid arthritis: A cohort study.". International journal of rheumatic diseases (2022): http://europepmc.org/abstract/med/35429115.
10.1111/1756-185x.14323
- Pierpaolo Pellicori; Muthiah Vaduganathan; João Pedro Ferreira; Faiez Zannad; Arun J. Sanyal. "Cross-talk between non-alcoholic
fatty liver disease and cardiovascular disease: implications for future trial design". Diabetes & Metabolism (2022):
101281-101281. https://doi.org/10.1016/j.diabet.2021.101281.
10.1016/j.diabet.2021.101281
- Ferreira JP; Butler J; Zannad F; Filippatos G; Schueler E; Steubl D; Zeller C; et al. "Mineralocorticoid Receptor Antagonists
and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction.". Journal of the American College of
Cardiology (2022): http://europepmc.org/abstract/med/35331406.
10.1016/j.jacc.2022.01.029
- Balasubramanian P; Wanner C; Ferreira JP; Ofstad AP; Elsaesser A; Zinman B; Inzucchi SE. "Empagliflozin and decreased risk
of nephrolithiasis: A potential new role for SGLT2 inhibition?". The Journal of clinical endocrinology and metabolism
(2022): http://europepmc.org/abstract/med/35290464.
10.1210/clinem/dgac154
- Abhinav Sharma; Amir Razaghizad; João Pedro Ferreira; Jean-Loup Machu; Erwan Bozec; Nicolas Girerd; Patrick Rossignol; Faiez
Zannad. "Metabolic syndrome and the risk of preclinical heart failure: Insights after 17 years of follow-up from the STANISLAS
Cohort". Cardiology (2022): https://doi.org/10.1159/000523717.
10.1159/000523717
- Javed Butler; Milton Packer; Gerasimos Filippatos; Joao Pedro Ferreira; Cordula Zeller; Janet Schnee; Martina Brueckmann;
et al. "Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction".
European Heart Journal 43 5 (2022): 416-426. https://doi.org/10.1093/eurheartj/ehab798.
10.1093/eurheartj/ehab798
- Ferreira JP; Packer M; Butler J; Zannad F. "Reconsidering the ejection fraction centric view of pharmacologic treatment for
heart failure.". European journal of heart failure (2022): http://europepmc.org/abstract/med/35191586.
10.1002/ejhf.2457
- Sharma A; Elharram M; Afilalo J; Flannery A; Afilalo M; Tselios C; Ni J; et al. "A Randomized Controlled Trial of Renin-Angiotensin-Aldosterone
System Inhibitor Management in Patients Admitted in Hospital with COVID-19.". American heart journal (2022): http://europepmc.org/abstract/med/35143744.
10.1016/j.ahj.2022.01.015
- Voors AA; Angermann CE; Teerlink JR; Collins SP; Kosiborod M; Biegus J; Ferreira JP; et al. "The SGLT2 inhibitor empagliflozin
in patients hospitalized for acute heart failure: a multinational randomized trial.". Nature medicine (2022): http://europepmc.org/abstract/med/35228754.
10.1038/s41591-021-01659-1
- Ferreira JP; Verdonschot JAJ; Girerd N; Bozec E; Pellicori P; Collier T; Mariottoni B; et al. "Influence of ejection fraction
on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial.".
European journal of heart failure (2022): http://europepmc.org/abstract/med/35199421.
10.1002/ejhf.2455
- João Pedro Ferreira; Jiankang Liu; Brian L. Claggett; Orly Vardeny; Bertram Pitt; Marc A. Pfeffer; Scott D. Solomon; Faiez
Zannad. "Outpatient diuretic intensification as endpoint in heart failure with preserved ejection fraction trials: an analysis
from TOPCAT". European Journal of Heart Failure (2022): https://doi.org/10.1002/ejhf.2376.
10.1002/ejhf.2376
- Javed Butler; Gerasimos Filippatos; Tariq Jamal Siddiqi; Martina Brueckmann; Michael Böhm; Vijay K. Chopra; João Pedro Ferreira;
et al. "Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction:
The EMPEROR-Preserved Trial". Circulation (2022): https://doi.org/10.1161/CIRCULATIONAHA.121.057812.
10.1161/CIRCULATIONAHA.121.057812
- João Pedro Ferreira; Stefan D. Anker; Javed Butler; Gerasimos Filippatos; Tomoko Iwata; Afshin Salsali; Cordula Zeller; et
al. "Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-
Reduced". European Journal of Heart Failure (2022): https://doi.org/10.1002/ejhf.2409.
10.1002/ejhf.2409
- João Pedro Ferreira; Silvio E. Inzucchi; Michaela Mattheus; Thomas Meinicke; Dominik Steubl; Christoph Wanner; Bernard Zinman.
"Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trial". Diabetes, Obesity
and Metabolism (2022): https://doi.org/10.1111/dom.14559.
10.1111/dom.14559
- Ferreira JP; Shah AM; Claggett BL; Pitt B; Lewis EF; Solomon SD; Zannad F. "Cardiac structure and function and quality of
life associations in HFpEF: An analysis from TOPCAT-Americas.". International journal of cardiology (2022): http://europepmc.org/abstract/med/35101539.
10.1016/j.ijcard.2022.01.053
- João Pedro Ferreira; John G. Cleland; Carolyn S. P. Lam; Stefan D. Anker; Mandeep R. Mehra; Dirk J. van Veldhuisen; William
M. Byra; et al. "New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis
from the COMMANDER-HF trial". Clinical Research in Cardiology (2022): https://doi.org/10.1007/s00392-021-01891-2.
10.1007/s00392-021-01891-2
- Butler J; Siddiqi TJ; Filippatos G; Ferreira JP; Pocock SJ; Zannad F; Anker SD. "Early Benefit with Empagliflozin in Heart
Failure with Preserved Ejection Fraction Insights from the EMPEROR-Preserved Trial.". European journal of heart failure
(2022): http://europepmc.org/abstract/med/34989083.
10.1002/ejhf.2420
- Martens P; Ferreira JP; Vincent J; Abreu P; Busselen M; Mullens W; Tang WHW; et al. "Prognostic relevance of magnesium alterations
in patients with a myocardial infarction and left ventricular dysfunction: insights from the EPHESUS trial.". European
heart journal. Acute cardiovascular care (2022): http://europepmc.org/abstract/med/35021200.
10.1093/ehjacc/zuab111
- Javed Butler; Stefan D Anker; Gerasimos Filippatos; Muhammad Shariq Usman; Joao Pedro Ferreira; Faiez Zannad; Milton Packer.
"Sodium glucose co-transporter inhibitors and heart failure outcomes across different patient populations". European Heart
Journal (2021): https://doi.org/10.1093/eurheartj/ehab704.
10.1093/eurheartj/ehab704
- João Pedro Ferreira; Patrick Rossignol; George Bakris; Cyrus Mehta; William B. White; Faiez Zannad. "Body weight changes in
patients with type 2 diabetes and a recent acute coronary syndrome: an analysis from the EXAMINE trial". Cardiovascular
Diabetology 20 1 (2021): https://doi.org/10.1186/s12933-021-01382-8.
10.1186/s12933-021-01382-8
- Verdonschot JAJ; Ferreira JP; Pizard A; Pellicori P; Brunner La Rocca HP; Clark AL; Cosmi F; et al. "The Effect of Spironolactone
in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE Trial.". Journal of cardiac failure
(2021): http://europepmc.org/abstract/med/34933097.
10.1016/j.cardfail.2021.12.005
- Luca Monzo; João Pedro Ferreira; Zohra Lamiral; Erwan Bozec; Jean-Marc Boivin; Olivier Huttin; Marilucy Lopez-Sublet; et al.
"Isolated diastolic hypertension and target organ damage: Findings from the STANISLAS cohort". Clinical Cardiology
(2021): https://doi.org/10.1002/clc.23713.
10.1002/clc.23713
- Carolyn S P Lam; João Pedro Ferreira; Egon Pfarr; David Sim; Hiroyuki Tsutsui; Stefan D Anker; Javed Butler; et al. "Regional
and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the
EMPEROR-Reduced trial". European Heart Journal 42 43 (2021): 4442-4451. https://doi.org/10.1093/eurheartj/ehab360.
10.1093/eurheartj/ehab360
- Stuart J Pocock; João Pedro Ferreira; John Gregson; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Nicholas D Gollop;
et al. "Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced
trial". European Heart Journal 42 43 (2021): 4455-4464. https://doi.org/10.1093/eurheartj/ehab579.
10.1093/eurheartj/ehab579
- Bertram Pitt; João Pedro Ferreira; Faiez Zannad. "Why are mineralocorticoid receptor antagonists the Cinderella in evidence-based
treatment of myocardial infarction complicated with heart failure? Lessons from PARADISE-MI". European Heart Journal
(2021): https://doi.org/10.1093/eurheartj/ehab717.
10.1093/eurheartj/ehab717
- Kobayashi M; Ferreira MB; Costa RQ; Fonseca T; Oliveira JC; Marinho A; Carvalho HC; et al. "Circulating Biomarkers and Cardiac
Structure and Function in Rheumatoid Arthritis.". Frontiers in cardiovascular medicine (2021): http://europepmc.org/abstract/med/34869664.
10.3389/fcvm.2021.754784
- Ravassa S; López B; Ferreira JP; Girerd N; Bozec E; Pellicori P; Mariottoni B; et al. "Biomarker-based assessment of collagen
cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial
remodelling. Insights from the HOMAGE clinical trial.". European journal of heart failure (2021): http://europepmc.org/abstract/med/34841615.
10.1002/ejhf.2394
- Ferreira JP; Rossignol P; Claggett BL; Solomon SD; Pitt B; Pfeffer M; Zannad F. "Weight changes in heart failure with preserved
ejection fraction: findings from TOPCAT.". Clinical research in cardiology : official journal of the German Cardiac Society
(2021): http://europepmc.org/abstract/med/34757487.
10.1007/s00392-021-01962-4
- Verma S; Dhingra NK; Butler J; Anker SD; Ferreira JP; Filippatos G; Januzzi JL; et al. "Empagliflozin in the treatment of
heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced):
a post-hoc analysis of a randomised, double-blind trial.". The lancet. Diabetes & endocrinology (2021): http://europepmc.org/abstract/med/34861154.
10.1016/s2213-8587(21)00292-8
- Ferreira J; Girerd N; Rocca H; Pellicori P; Cleland J; Rossignol P; Zannad F. "No influence of spironolactone on plasma concentrations
of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial Pas d’influence de la spironolactone sur les
concentrations plasmatiques de l’enzyme de conversion de l’angiotensine 2 : résultats de l’essai randomisé HOMAGE". Archives
of cardiovascular diseases (2021): http://europepmc.org/abstract/PMC/PMC8576594.
- João Pedro Ferreira; John G. Cleland; Carolyn S. P. Lam; Stefan D. Anker; Mandeep R. Mehra; Dirk J. van Veldhuisen; William
M. Byra; et al. "Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF,
EPHESUS, and EXAMINE". Clinical Research in Cardiology (2021): https://doi.org/10.1007/s00392-021-01830-1.
10.1007/s00392-021-01830-1
- Lourenço P; Ferreira JP; Leite-Moreira A; Ferreira AL. "Obituary: Paulo Bettencourt 1965-2021.". European journal of heart
failure (2021): http://europepmc.org/abstract/med/34622532.
10.1002/ejhf.2359
- Böhm M; Anker SD; Butler J; Filippatos G; Ferreira JP; Pocock SJ; Mahfoud F; et al. "Empagliflozin Improves Cardiovascular
and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure.". Journal of the American College of Cardiology
(2021): http://europepmc.org/abstract/med/34556320.
10.1016/j.jacc.2021.07.049
- Januzzi JL; Zannad F; Anker SD; Butler J; Filippatos G; Pocock SJ; Ferreira JP; et al. "Prognostic Importance of NT-proBNP
and Effect of Empagliflozin in the EMPEROR-Reduced Trial.". Journal of the American College of Cardiology (2021): http://europepmc.org/abstract/med/34556318.
10.1016/j.jacc.2021.07.046
- Yeoh SE; Dewan P; Serenelli M; Ferreira JP; Pitt B; Swedberg K; van Veldhuisen DJ; et al. "Effects of mineralocorticoid receptor
antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF
and RALES.". European journal of heart failure (2021): http://europepmc.org/abstract/med/34536265.
10.1002/ejhf.2350
- Kobayashi M; Huttin O; Magnusson M; Ferreira JP; Bozec E; Huby AC; Preud'homme G; et al. "Machine Learning-Derived Echocardiographic
Phenotypes Predict Heart Failure Incidence in Asymptomatic Individuals.". JACC. Cardiovascular imaging (2021): http://europepmc.org/abstract/med/34538625.
10.1016/j.jcmg.2021.07.004
- Milton Packer; Javed Butler; Faiez Zannad; Gerasimos Filippatos; Joao Pedro Ferreira; Stuart J. Pocock; Peter Carson; et al.
"Effect of Empagliflozin on Worsening Heart Failure Events in Patients with Heart Failure and a Preserved Ejection Fraction:
The EMPEROR-Preserved Trial". Circulation (2021): https://doi.org/10.1161/CIRCULATIONAHA.121.056824.
10.1161/CIRCULATIONAHA.121.056824
- Anker SD; Butler J; Filippatos G; Ferreira JP; Bocchi E; Böhm M; Brunner-La Rocca HP; et al. "Empagliflozin in Heart Failure
with a Preserved Ejection Fraction.". The New England journal of medicine (2021): http://europepmc.org/abstract/med/34449189.
10.1056/nejmoa2107038
- Verdonschot JAJ; Ferreira JP; Pellicori P; Brunner-La Rocca HP; Clark AL; Cosmi F; Cuthbert J; et al. "Proteomic mechanistic
profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial.". Cardiovascular
diabetology (2021): http://europepmc.org/abstract/med/34372849.
10.1186/s12933-021-01357-9
- Kasiakogias A; Rosei EA; Camafort M; Ehret G; Faconti L; Ferreira JP; Brguljan J; et al. "Hypertension and heart failure with
preserved ejection fraction: position paper by the European Society of Hypertension.". Journal of hypertension (2021):
http://europepmc.org/abstract/med/34102660.
10.1097/hjh.0000000000002910
- Noirclerc N; Huttin O; de Chillou C; Selton-Suty C; Fillipetti L; Sellal JM; Bozec E; et al. "Cardiac Remodeling and Diastolic
Dysfunction in Paroxysmal Atrial Fibrillation.". Journal of clinical medicine (2021): http://europepmc.org/abstract/med/34501342.
10.3390/jcm10173894
- Packer M; Butler J; Zannad F; Pocock SJ; Filippatos G; Ferreira JP; Brueckmann M; et al. "Empagliflozin and Major Renal Outcomes
in Heart Failure.". The New England journal of medicine (2021): http://europepmc.org/abstract/med/34449179.
10.1056/nejmc2112411
- Packer M; Zannad F; Butler J; Filippatos G; Ferreira JP; Pocock SJ; Brueckmann M; et al. "Influence of endpoint definitions
on the effect of empagliflozin on major renal outcomes in the EMPEROR-Preserved trial.". European journal of heart failure
(2021): http://europepmc.org/abstract/med/34459076.
10.1002/ejhf.2334
- João Pedro Ferreira; Zohra Lamiral; George Bakris; Cyrus Mehta; William B. White; Faiez Zannad. "Red cell distribution width
in patients with diabetes and myocardial infarction: An analysis from the EXAMINE trial". Diabetes, Obesity and Metabolism
23 7 (2021): 1580-1587. https://doi.org/10.1111/dom.14371.
10.1111/dom.14371
- Docherty KF; Jhund PS; Claggett B; Ferreira JP; Bengtsson O; Inzucchi SE; Køber L; et al. "Extrapolating Long-term Event-Free
and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis
of a Phase 3 Randomized Clinical Trial.". JAMA cardiology (2021): http://europepmc.org/abstract/med/34319398.
10.1001/jamacardio.2021.2632
- João Pedro Ferreira; Diana Ferrao; Patrick Rossignol; Faiez Zannad; Abhinav Sharma; Francisco Vasques-Novoa; Adelino Leite-Moreira.
"Interplay between worsening kidney function and cardiovascular events in patients with type 2 diabetes: an analysis from
the ACCORD trial". BMJ Open Diabetes Research & Care (2021): https://doi.org/10.1136/bmjdrc-2021-002408.
10.1136/bmjdrc-2021-002408
- Raafs A; Verdonschot J; Ferreira JP; Wang P; Collier T; Henkens M; Björkman J; et al. "Identification of sex-specific biomarkers
predicting new-onset heart failure.". ESC heart failure (2021): http://europepmc.org/abstract/med/34156155.
10.1002/ehf2.13476
- João Pedro Ferreira; Zohra Lamiral; John J.V. McMurray; Karl Swedberg; Dirk J. van Veldhuisen; John Vincent; Patrick Rossignol;
et al. "Impact of Insulin Treatment on the Effect of Eplerenone: Insights From the EMPHASIS-HF Trial". Circulation: Heart
Failure 14 6 (2021): https://doi.org/10.1161/CIRCHEARTFAILURE.120.008075.
10.1161/CIRCHEARTFAILURE.120.008075
- João Pedro Ferreira; John Gregson; Michael Böhm; Patrick Rossignol; Faiez Zannad; Stuart J. Pocock. "Blood pressure reduction
and anti-hypertensive treatment choice: A post-hoc analysis of the SPRINT trial". Clinical Cardiology (2021): https://doi.org/10.1002/clc.23591.
10.1002/clc.23591
- Ferreira JP. "Omecamtiv Mecarbil: A Personalized Treatment for Patients With Severely Impaired Ejection Fraction.". Journal
of the American College of Cardiology (2021): http://europepmc.org/abstract/med/34015476.
10.1016/j.jacc.2021.04.077
- Ferreira JP. "Circulating levels of procollagen type I carboxy-terminal propeptide reflect myocardial fibrosis.". European
journal of heart failure (2021): http://europepmc.org/abstract/med/33966350.
10.1002/ejhf.2216
- Kobayashi M; Voors AA; Ouwerkerk W; Duarte K; Girerd N; Rossignol P; Metra M; et al. "Perceived risk profile and treatment
optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure.". Clinical
cardiology (2021): http://europepmc.org/abstract/med/33960439.
10.1002/clc.23576
- Packer M; Januzzi JL; Ferreira JP; Anker SD; Butler J; Filippatos G; Pocock SJ; et al. "Concentration-dependent clinical and
prognostic importance of high-sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence
of empagliflozin: the EMPEROR-Reduced trial.". European journal of heart failure (2021): http://europepmc.org/abstract/med/34053177.
10.1002/ejhf.2256
- Ferreira JP; Konstam MA; McMurray JJV; Butler J; Girerd N; Rossignol P; Sharma A; et al. "Dosing of losartan in men versus
women with heart failure with reduced ejection fraction: the HEAAL trial.". European journal of heart failure (2021):
http://europepmc.org/abstract/med/34050594.
10.1002/ejhf.2255
- João Pedro Ferreira; Bettina Johanna Kraus; Isabella Zwiener; Sabine Lauer; Bernard Zinman; David H. Fitchett; Audrey Koitka-Weber;
et al. "Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial". Journal of the American
Heart Association 10 7 (2021): https://doi.org/10.1161/JAHA.120.020053.
10.1161/JAHA.120.020053
- Rossello X; Ferreira JP; Caimari F; Lamiral Z; Sharma A; Mehta C; Bakris G; et al. "Influence of sex, age and race on coronary
and heart failure events in patients with diabetes and post-acute coronary syndrome.". Clinical research in cardiology
: official journal of the German Cardiac Society (2021): http://europepmc.org/abstract/med/33929598.
10.1007/s00392-021-01859-2
- Ferreira JP; Collier T; Clark AL; Mamas MA; Rocca HB; Heymans S; González A; et al. "Spironolactone effect on the blood pressure
of patients at risk of developing heart failure: an analysis from the HOMAGE trial.". European heart journal. Cardiovascular
pharmacotherapy (2021): http://europepmc.org/abstract/med/33822033.
10.1093/ehjcvp/pvab031
- Martens P; Ferreira JP; Vincent J; Abreu P; Busselen M; Mullens W; Tang WWH; et al. "Serum sodium and eplerenone use in patients
with a myocardial infarction and left ventricular dysfunction or heart failure: insights from the EPHESUS trial.". Clinical
research in cardiology : official journal of the German Cardiac Society (2021): http://europepmc.org/abstract/med/33893561.
10.1007/s00392-021-01853-8
- Hui SK; Sharma A; Docherty K; McMurray JJV; Pitt B; Dickstein K; Pfeffer MA; et al. "Non-fatal cardiovascular events preceding
sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk
myocardial infarction database.". European heart journal. Acute cardiovascular care (2021): http://europepmc.org/abstract/med/33620418.
10.1093/ehjacc/zuaa012
- Ferreira JP. "Cognitive function assessment for personalized heart failure disease management programmes.". European journal
of heart failure (2021): http://europepmc.org/abstract/med/33826218.
10.1002/ejhf.2183
- Ravera A; Santema BT; Sama IE; Meyer S; Lombardi CM; Carubelli V; Ferreira JP; et al. "Quality of life in men and women with
heart failure: association with outcome, and comparison of the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5
dimensions questionnaire.". European journal of heart failure (2021): http://europepmc.org/abstract/med/33728762.
10.1002/ejhf.2154
- Stienen S; Ferreira JP; Bär C; Thum T; Barros A; Pitt B; Girerd N; Rossignol P; Zannad F. "Serum microRNAs and antifibrotic
response to eplerenone in acute myocardial infarction complicated by systolic dysfunction.". International journal of cardiology
(2021): http://europepmc.org/abstract/med/33676945.
10.1016/j.ijcard.2021.02.088
- Packer M; Anker SD; Butler J; Filippatos G; Ferreira JP; Pocock SJ; Sattar N; et al. "Empagliflozin in Patients With Heart Failure,
Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.". Journal of the American College of Cardiology
(2021): http://europepmc.org/abstract/med/33736819.
10.1016/j.jacc.2021.01.033
- Ferreira JP; Zannad F; Pocock SJ; Anker SD; Butler J; Filippatos G; Brueckmann M; et al. "Interplay of Mineralocorticoid Receptor
Antagonists and Empagliflozin in Heart Failure: EMPEROR-Reduced.". Journal of the American College of Cardiology (2021):
http://europepmc.org/abstract/med/33736821.
10.1016/j.jacc.2021.01.044
- Ferreira JP; Oliveira AC; Saraiva FA; Vasques-Nóvoa F; Leite-Moreira A. "Sodium-glucose co-transporter inhibitors in insulin-treated
diabetes: a meta-analysis.". European journal of endocrinology (2021): http://europepmc.org/abstract/med/33769961.
10.1530/eje-20-1484
- João Pedro Ferreira; Michael Böhm; Patrick Rossignol; Faiez Zannad. "Impact of anti-hypertensive therapy in the sexual health
of men and women: an analysis from the SPRINT trial". American Journal of Hypertension (2021): https://doi.org/10.1093/ajh/hpab035.
10.1093/ajh/hpab035
- João Pedro Ferreira; Murray Epstein; Faiez Zannad. "The Decline of the Experimental Paradigm During the COVID-19 Pandemic:
A Template for the Future". The American Journal of Medicine (2021): https://doi.org/10.1016/j.amjmed.2020.08.021.
10.1016/j.amjmed.2020.08.021
- Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; et al. "Management of Renin-Angiotensin-Aldosterone
System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID-
19): A structured summary of a study protocol for a randomized controlled trial.". Trials (2021): http://europepmc.org/abstract/med/33546734.
10.1186/s13063-021-05080-4
- Huttin O; Kobayashi M; Ferreira JP; Coiro S; Bozec E; Selton-Suty C; Filipetti L; et al. "Circulating multimarker approach
to identify patients with preclinical left ventricular remodelling and/or diastolic dysfunction.". ESC heart failure
(2021): http://europepmc.org/abstract/med/33576580.
10.1002/ehf2.13203
- Tromp J; Ponikowski P; Salsali A; Angermann CE; Biegus J; Blatchford J; Collins SP; et al. "Sodium-glucose co-transporter
2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial.".
European journal of heart failure (2021): http://europepmc.org/abstract/med/33609072.
10.1002/ejhf.2137
- Ferreira JP; Claggett BL; Liu J; Desai AS; Pfeffer MA; Anand IS; Van Veldhuisen DJ; et al. "Serum potassium and outcomes in
heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial.". European journal of heart
failure (2021): http://europepmc.org/abstract/med/33609066.
10.1002/ejhf.2134
- Preud'homme G; Duarte K; Dalleau K; Lacomblez C; Bresso E; Smaïl-Tabbone M; Couceiro M; et al. "Head-to-head comparison of
clustering methods for heterogeneous data: a simulation-driven benchmark.". Scientific reports (2021): http://europepmc.org/abstract/med/33603019.
10.1038/s41598-021-83340-8
- Faiez Zannad; João Pedro Ferreira; Stuart J. Pocock; Cordula Zeller; Stefan D. Anker; Javed Butler; Gerasimos Filippatos;
et al. "Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function". Circulation
(2021): https://doi.org/10.1161/CIRCULATIONAHA.120.051685.
10.1161/CIRCULATIONAHA.120.051685
- Milton Packer; Stefan D. Anker; Javed Butler; Gerasimos Filippatos; João Pedro Ferreira; Stuart J. Pocock; Peter Carson; et
al. "Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction". Circulation
(2021): https://doi.org/10.1161/CIRCULATIONAHA.120.051783.
10.1161/CIRCULATIONAHA.120.051783
- Ravi B. Patel; Jozine Magdalena ter Maaten; João Pedro Ferreira; Finnian R. Mc Causland; Sanjiv J. Shah; Patrick Rossignol;
Scott D. Solomon; et al. "Challenges of Cardio-Kidney Composite Outcomes in Large-Scale Clinical Trials". Circulation
(2021): https://doi.org/10.1161/CIRCULATIONAHA.120.049514.
10.1161/CIRCULATIONAHA.120.049514
- Malik Elharram; João Pedro Ferreira; Thao Huynh; Jiayi Ni; Nadia Giannetti; Subodh Verma; Faiez Zannad; Abhinav Sharma. "Prediction
of heart failure outcomes in patients with type 2 diabetes mellitus: Validation of the Thrombolysis in Myocardial Infarction
Risk Score for Heart Failure in Diabetes ( TRS-HF DM ) in patients in the ACCORD trial". Diabetes, Obesity and Metabolism
(2021): https://doi.org/10.1111/dom.14283.
10.1111/dom.14283
- Butler J; Anker SD; Filippatos G; Khan MS; Ferreira JP; Pocock SJ; Giannetti N; et al. "Empagliflozin and health-related quality
of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial.". European heart
journal (2021): http://europepmc.org/abstract/med/33420498.
10.1093/eurheartj/ehaa1007
- Packer M; Anker SD; Butler J; Filippatos G; Ferreira JP; Pocock SJ; Rocca HB; et al. "Influence of neprilysin inhibition on
the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced
trial.". European heart journal (2021): http://europepmc.org/abstract/med/33459776.
10.1093/eurheartj/ehaa968
- Ferreira JP; Verdonschot J; Wang P; Pizard A; Collier T; Ahmed FZ; Brunner-La-Rocca HP; et al. "Proteomic and Mechanistic
Analysis of Spironolactone in Patients at Risk for HF.". JACC. Heart failure (2021): http://europepmc.org/abstract/med/33549556.
10.1016/j.jchf.2020.11.010
- Ferreira JP; Cleland JGF; Lam CSP; van Veldhuisen D; Byra WM; La Police DA; Anker SD; et al. "Impact of Geographic Region
on the COMMANDER-HF Trial.". JACC. Heart failure (2021): http://europepmc.org/abstract/med/33549557.
10.1016/j.jchf.2020.11.007
- João Pedro Ferreira; Patrick Rossignol; George Bakris; Cyrus Mehta; William B. White; Faiez Zannad. "Blood and Urine Biomarkers
Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE
Trial". American Journal of Nephrology 52 12 (2021): 969-976. https://doi.org/10.1159/000519436.
10.1159/000519436
- João Pedro Ferreira; Abhinav Sharma; Faiez Zannad. "The Future of Meat: Health Impact Assessment with Randomized Evidence".
The American Journal of Medicine (2020): https://doi.org/10.1016/j.amjmed.2020.11.007.
10.1016/j.amjmed.2020.11.007
- João Pedro Ferreira; Subodh Verma; David Fitchett; Anne Pernille Ofstad; Sabine Lauer; Isabella Zwiener; Jyothis George; et
al. "Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of
the EMPA-REG OUTCOME trial". Cardiovascular Diabetology (2020): https://doi.org/10.1186/s12933-020-01174-6.
10.1186/s12933-020-01174-6
- Ferreira JP; Couchoud C; Edet S; Brunet P; Frimat L. "Adverse gastrointestinal events with sodium polystyrene sulphonate and
calcium polystyrene sulphonate use in dialysis patients: a nationwide registry study.". Nephrology, dialysis, transplantation
: official publication of the European Dialysis and Transplant Association - European Renal Association (2020): http://europepmc.org/abstract/med/33247730.
10.1093/ndt/gfaa229
- Anker SD; Butler J; Filippatos G; Khan MS; Ferreira JP; Bocchi E; Böhm M; et al. "Baseline Characteristics of Patients with
Heart Failure with Preserved Ejection Fraction in the EMPEROR-Preserved Trial.". European journal of heart failure
(2020): http://europepmc.org/abstract/med/33251670.
10.1002/ejhf.2064
- Anker SD; Butler J; Filippatos G; Khan MS; Marx N; Lam CSP; Schnaidt S; et al. "Effect of Empagliflozin on Cardiovascular
and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial.".
Circulation (2020): http://europepmc.org/abstract/med/33175585.
10.1161/circulationaha.120.051824
- Packer M; Butler J; Filippatos G; Zannad F; Ferreira JP; Zeller C; Brueckmann M; et al. "Design of a Prospective Patient-Level
Pooled Analysis of Two Parallel Trials of Empagliflozin in Patients With Established Heart Failure.". European journal
of heart failure (2020): http://europepmc.org/abstract/med/33251659.
10.1002/ejhf.2065
- Cleland JGF; Ferreira JP; Mariottoni B; Pellicori P; Cuthbert J; Verdonschot JAJ; Petutschnigg J; et al. "The effect of spironolactone
on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics'
in AGEing (HOMAGE) randomized clinical trial.". European heart journal (2020): http://europepmc.org/abstract/med/33215209.
10.1093/eurheartj/ehaa758
- Jering KS; Zannad F; Claggett B; Mc Causland FR; Ferreira JP; Desai A; Barkoudah E; et al. "Cardiovascular and Renal Outcomes
of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF.". JACC. Heart failure (2020): http://europepmc.org/abstract/med/33189633.
10.1016/j.jchf.2020.08.014
- Ferreira MB; Fonseca T; Costa R; Marinhoc A; Carvalho HC; Oliveira JC; Zannad F; et al. "Prevalence, risk factors and proteomic
bioprofiles associated with heart failure in rheumatoid arthritis: The RA-HF study.". European journal of internal medicine
(2020): http://europepmc.org/abstract/med/33162300.
10.1016/j.ejim.2020.11.002
- João Pedro Ferreira; Wouter Ouwerkerk; Bernadet T Santema; Dirk J van Veldhuisen; Chim C Lang; Leong L Ng; Stefan D Anker;
et al. "Differences in biomarkers and molecular pathways according to age for patients with HFrEF". Cardiovascular Research
(2020): https://doi.org/10.1093/cvr/cvaa279.
10.1093/cvr/cvaa279
- Rodrigues P; Ferreira B; Fonseca T; Costa RQ; Cabral S; Pinto JL; Saraiva F; et al. "Subclinical ventricular dysfunction in
rheumatoid arthritis.". The international journal of cardiovascular imaging (2020): http://europepmc.org/abstract/med/33052554.
10.1007/s10554-020-02057-3
- Ferreira JP; Docherty KF; Stienen S; Jhund PS; Claggett BL; Solomon SD; Petrie MC; et al. "Estimating the Lifetime Benefits
of Treatments for Heart Failure.". JACC. Heart failure (2020): http://europepmc.org/abstract/med/33039448.
10.1016/j.jchf.2020.08.004
- Cunningham JW; Ferreira JP; Zannad F. "Reply: Natriuretic Peptide Measurement Is Key to a Solution in the Clinical Trial and
Clinical Practice.". JACC. Heart failure (2020): http://europepmc.org/abstract/med/32883442.
10.1016/j.jchf.2020.07.001
- Ferreira JP; Lamiral Z; Xhaard C; Duarte K; Bresso E; Devignes MD; Le Floch E; et al. "Circulating plasma proteins and new-onset
diabetes in a population-based study: proteomic and genomic insights from the STANISLAS cohort.". European journal of endocrinology
(2020): http://europepmc.org/abstract/med/32567559.
10.1530/eje-20-0246
- Ferreira JP; Lam CSP; Anker SD; Mehra MR; van Veldhuisen DJ; Byra WM; La Police DA; et al. "Plasma D-dimer concentrations
predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER-HF
trial.". European journal of heart failure (2020): http://europepmc.org/abstract/med/32959502.
10.1002/ejhf.2003
- João Pedro Ferreira; Abhinav Sharma; Cyrus Mehta; George Bakris; Patrick Rossignol; William B. White; Faiez Zannad. "Multi-proteomic
approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the
EXAMINE trial". Clinical Research in Cardiology (2020): https://doi.org/10.1007/s00392-020-01729-3.
10.1007/s00392-020-01729-3
- Zannad F; Ferreira JP; Pocock SJ; Anker SD; Butler J; Filippatos G; Brueckmann M; et al. "SGLT2 inhibitors in patients with
heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.". Lancet (London,
England) (2020): http://europepmc.org/abstract/med/32877652.
10.1016/s0140-6736(20)31824-9
- Stienen S; Ferreira JP; Kobayashi M; Preud'homme G; Dobre D; Machu JL; Duarte K; et al. "Sex differences in circulating proteins
in heart failure with preserved ejection fraction.". Biology of sex differences (2020): http://europepmc.org/abstract/med/32831121.
10.1186/s13293-020-00322-7
- Ferreira JP; Mogensen UM; Jhund PS; Desai AS; Rouleau JL; Zile MR; Rossignol P; et al. "Serum Potassium in the PARADIGM-HF
trial.". European journal of heart failure (2020): http://europepmc.org/abstract/med/32809261.
10.1002/ejhf.1987
- Stienen S; Bhatt A; Ferreira JP; Vaduganathan M; Januzzi J; Adams K; Tardif JC; Rossignol P; Zannad F. "Bias in natriuretic
peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches.". Heart failure
reviews (2020): http://europepmc.org/abstract/med/32783110.
10.1007/s10741-020-10004-6
- Abensur Vuillaume L; Ferreira JP; Asseray N; Trombert-Paviot B; Montassier E; Legrand M; Girerd N; et al. "Hypokalemia is
frequent and has prognostic implications in stable patients attending the emergency department.". PloS one (2020):
http://europepmc.org/abstract/med/32750075.
10.1371/journal.pone.0236934
- Schrage B; Lund LH; Benson L; Stolfo D; Ohlsson A; Westerling R; Westermann D; et al. "Lower socioeconomic status predicts
higher mortality and morbidity in patients with heart failure.". Heart (British Cardiac Society) (2020): http://europepmc.org/abstract/med/32769169.
10.1136/heartjnl-2020-317216
- Elharram M; Sharma A; White W; Bakris G; Rossignol P; Mehta C; Ferreira JP; Zannad F. "Timing of randomization after an acute
coronary syndrome in patients with type 2 diabetes mellitus.". American heart journal (2020): http://europepmc.org/abstract/med/32916607.
10.1016/j.ahj.2020.07.014
- Ferreira JP; Mehta C; Sharma A; Nissen SE; Rossignol P; Zannad F. "Alogliptin after acute coronary syndrome in patients with
type 2 diabetes: a renal function stratified analysis of the EXAMINE trial.". BMC medicine (2020): http://europepmc.org/abstract/med/32493335.
10.1186/s12916-020-01616-8
- Ferreira JP; Butler J; Rossignol P; Pitt B; Anker SD; Kosiborod M; Lund LH; et al. "Abnormalities of Potassium in Heart Failure:
JACC State-of-the-Art Review.". Journal of the American College of Cardiology (2020): http://europepmc.org/abstract/med/32498812.
10.1016/j.jacc.2020.04.021
- Ferreira JP; Jhund PS; Duarte K; Claggett BL; Solomon SD; Pocock S; Petrie MC; Zannad F; McMurray JJV. "Use of the Win Ratio
in Cardiovascular Trials.". JACC. Heart failure (2020): http://europepmc.org/abstract/med/32466836.
10.1016/j.jchf.2020.02.010
- João Pedro Ferreira; David Fitchett; Anne Pernille Ofstad; Bettina Johanna Kraus; Christoph Wanner; Isabella Zwiener; Bernard
Zinman; et al. "Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME
Trial". American Journal of Hypertension (2020): https://doi.org/10.1093/ajh/hpaa073.
10.1093/ajh/hpaa073
- Ferreira JP; Eschalier R; Duarte K; Damman K; Gustafsson F; Schou M; Girerd N; et al. "Reduced Diuretic Dose in Patients Treated
With Eplerenone: Data From the EPHESUS Trial.". Circulation. Heart failure (2020): http://europepmc.org/abstract/med/32354280.
10.1161/circheartfailure.119.006597
- Ferreira JP; Rossello X; Pocock SJ; Rossignol P; Claggett BL; Rouleau JL; Solomon SD; et al. "Spironolactone dose in heart
failure with preserved ejection fraction: findings from TOPCAT.". European journal of heart failure (2020): http://europepmc.org/abstract/med/32452128.
10.1002/ejhf.1909
- Vaduganathan M; Claggett BL; Jhund PS; Cunningham JW; Pedro Ferreira J; Zannad F; Packer M; et al. "Estimating lifetime benefits
of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction:
a comparative analysis of three randomised controlled trials.". Lancet (London, England) (2020): http://europepmc.org/abstract/med/32446323.
10.1016/s0140-6736(20)30748-0
- Stienen S; Ferreira JP; Pitt B; Cleland JG; Pellicori P; Girerd N; Rossignol P; Zannad F. "Eplerenone prevents an increase
in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction
and/or heart failure.". European journal of heart failure (2020): http://europepmc.org/abstract/med/32243646.
- de Denus S; Leclair G; Dubé MP; St-Jean I; Zada YF; Oussaïd E; Jutras M; et al. "Spironolactone metabolite concentrations
in decompensated heart failure: insights from the ATHENA-HF trial.". European journal of heart failure (2020): http://europepmc.org/abstract/med/32237012.
- Kanbay M; Girerd N; Machu JL; Bozec E; Duarte K; Boivin JM; Wagner S; et al. "Impact of Uric Acid on Hypertension Occurrence
and Target Organ Damage: Insights From the STANISLAS Cohort With a 20-Year Follow-up.". American journal of hypertension
(2020): http://europepmc.org/abstract/med/32267470.
10.1093/ajh/hpaa030
- Ferreira JP. "Health-related quality of life scores: ending the minimum 5-point difference as the clinically meaningful threshold.".
European journal of heart failure (2020): http://europepmc.org/abstract/med/32297433.
10.1002/ejhf.1822
- Almufleh A; Desai AS; Fay R; Ferreira JP; Buckley LF; Mehra MR; Rossignol P; Zannad F. "Correlation of laboratory haemoconcentration
measures with filling pressures obtained via pulmonary arterial pressure sensors in ambulatory heart failure patients.". European
journal of heart failure (2020): http://europepmc.org/abstract/med/32353199.
10.1002/ejhf.1848
- Elharram M; Ferreira JP; Sharma A. "The intersecting role of glycaemia and cardiac function in the development of heart failure
among patients with type 2 diabetes mellitus after an acute coronary syndrome.". European journal of heart failure
(2020): http://europepmc.org/abstract/med/32353172.
10.1002/ejhf.1845
- Dewan P; Jackson A; Jhund PS; Shen L; Ferreira JP; Petrie MC; Abraham WT; et al. "The prevalence and importance of frailty
in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE.". European journal of heart
failure (2020): http://europepmc.org/abstract/med/32353205.
10.1002/ejhf.1832
- Böhm M; Ferreira JP; Mahfoud F; Duarte K; Pitt B; Zannad F; Rossignol P; et al. "Myocardial reperfusion reverses the J-curve
association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure
after myocardial infarction: insights from the EPHESUS trial.". European heart journal (2020): http://europepmc.org/abstract/med/32118256.
10.1093/eurheartj/ehaa132
- Kobayashi M; Stienen S; Ter Maaten JM; Dickstein K; Samani NJ; Lang CC; Ng LL; et al. "Clinical determinants and prognostic
implications of renin and aldosterone in patients with symptomatic heart failure.". ESC heart failure (2020): http://europepmc.org/abstract/med/32167681.
- Cunningham JW; Ferreira JP; Deng H; Anker SD; Byra WM; Cleland JGF; Gheorghiade M; et al. "Natriuretic Peptide-Based Inclusion
Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HF.". JACC. Heart failure (2020): http://europepmc.org/abstract/med/32171760.
- Ferreira JP; Dewan P; Jhund PS; Lorenzo-Almorós A; Duarte K; Petrie MC; Carson PE; et al. "Covariate adjusted reanalysis of
the I-Preserve trial.". Clinical research in cardiology : official journal of the German Cardiac Society (2020): http://europepmc.org/abstract/med/32215700.
- Ferreira JP; Xhaard C; Lamiral Z; Borges-Canha M; Neves JS; Dandine-Roulland C; LeFloch E; et al. "PCSK9 Protein and rs562556
Polymorphism Are Associated With Arterial Plaques in Healthy Middle-Aged Population: The STANISLAS Cohort.". Journal of
the American Heart Association (2020): http://europepmc.org/abstract/med/32208829.
- Rossello X; Ferreira JP; Pocock SJ; McMurray JJV; Solomon SD; Lam CSP; Girerd N; et al. "Sex differences in mineralocorticoid
receptor antagonist trials: a pooled analysis of three large clinical trials.". European journal of heart failure (2020):
http://europepmc.org/abstract/med/32077220.
10.1002/ejhf.1740
- Stienen S; Ferreira JP; Kobayashi M; Preud'homme G; Dobre D; Machu JL; Duarte K; et al. "Enhanced clinical phenotyping by
mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic
Road to Diastolic Heart Failure).". Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
(2020): http://europepmc.org/abstract/med/32063068.
10.1080/1354750x.2020.1727015
- Triantafyllou A; Ferreira JP; Kobayashi M; Micard E; Xie Y; Kearney-Schwartz A; Hossu G; et al. "Longer Duration of Hypertension
and MRI Microvascular Brain Alterations Are Associated with Lower Hippocampal Volumes in Older Individuals with Hypertension.".
Journal of Alzheimer's disease : JAD (2020): http://europepmc.org/abstract/med/32039844.
10.3233/jad-190842
- Ferreira JP; Duarte K; Woehrle H; Cowie MR; Wegscheider K; Angermann C; d'Ortho MP; et al. "Biomarkers in patients with heart
failure and central sleep apnoea: findings from the SERVE-HF trial.". ESC heart failure (2020): http://europepmc.org/abstract/med/31951323.
10.1002/ehf2.12521
- Pellicori P; Ferreira JP; Mariottoni B; Brunner-La Rocca HP; Ahmed FZ; Verdonschot J; Collier T; et al. "Effects of spironolactone
on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics
of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial.". European
journal of heart failure (2020): http://europepmc.org/abstract/med/31950604.
10.1002/ejhf.1716
- Docherty KF; Ferreira JP; Sharma A; Girerd N; Gregson J; Duarte K; Petrie MC; et al. "Predictors of sudden cardiac death in
high-risk patients following a myocardial infarction.". European journal of heart failure (2020): http://europepmc.org/abstract/med/31944496.
10.1002/ejhf.1694
- Petutschnigg J; Ferreira JP; Holzendorf V; Trippel TD; Hashemi D; Wachter R; Herrmann-Lingen C; et al. "Body fat phenotypes
and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post-hoc
analysis of the Aldo-DHF trial.". European journal of heart failure (2020): http://europepmc.org/abstract/med/31912594.
10.1002/ejhf.1723
- Serenelli M; Jackson A; Dewan P; Jhund PS; Petrie MC; Rossignol P; Campo G; et al. "Mineralocorticoid Receptor Antagonists,
Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction.". JACC. Heart failure (2020): http://europepmc.org/abstract/med/31926854.
10.1016/j.jchf.2019.09.011
- Sharma A; Vaduganathan M; Ferreira JP; Liu Y; Bakris GL; Cannon CP; White WB; Zannad F. "Clinical and Biomarker Predictors
of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights
From the EXAMINE Trial.". Journal of the American Heart Association (2020): http://europepmc.org/abstract/med/31902327.
10.1161/jaha.119.012797
- Lombardi CM; Ferreira JP; Carubelli V; Anker SD; Cleland JG; Dickstein K; Filippatos G; et al. "Geographical differences in
heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study.". Clinical research in cardiology
: official journal of the German Cardiac Society (2020): http://europepmc.org/abstract/med/31996990.
10.1007/s00392-019-01588-7
- Tromp J; Voors AA; Sharma A; Ferreira JP; Ouwerkerk W; Hillege HL; Gomez KA; et al. "Distinct Pathological Pathways in Patients
With Heart Failure and Diabetes.". JACC. Heart failure (2020): http://europepmc.org/abstract/med/32035890.
Publicado • 10.1016/j.jchf.2019.11.005
- Ferreira JP; Rossello X; Eschalier R; McMurray JJV; Pocock S; Girerd N; Rossignol P; Pitt B; Zannad F. "MRAs in Elderly HF
Patients: Individual Patient-Data Meta-Analysis of RALES, EMPAHSIS-HF, and TOPCAT.". JACC. Heart failure (2019): http://europepmc.org/abstract/med/31779922.
10.1016/j.jchf.2019.08.017
- Xhaard C; Dandine-Roulland C; Villemereuil P; Floch EL; Bacq-Daian D; Machu JL; Ferreira JP; et al. "Heritability of a resting
heart rate in a 20-year follow-up family cohort with GWAS data: Insights from the STANISLAS cohort.". European journal
of preventive cardiology (2019): http://europepmc.org/abstract/med/31791143.
10.1177/2047487319890763
- Ferreira JP; Ouwerkerk W; Tromp J; Ng L; Dickstein K; Anker S; Filippatos G; et al. "Cardiovascular and non-cardiovascular
death distinction: the utility of troponin beyond N-terminal pro-B-type natriuretic peptide. Findings from the BIOSTAT-CHF
study.". European journal of heart failure (2019): http://europepmc.org/abstract/med/31793144.
10.1002/ejhf.1654
- João Pedro Ferreira; Kévin Duarte; Holger Woehrle; Martin R. Cowie; Christiane Angermann; Marie-Pia d’Ortho; Erland Erdmann;
et al. "Bioprofiles and mechanistic pathways associated with Cheyne-Stokes respiration: insights from the SERVE-HF trial".
Clinical Research in Cardiology (2019): https://doi.org/10.1007/s00392-019-01578-9.
10.1007/s00392-019-01578-9
- João Pedro Ferreira; Xavier Rossello; Bertram Pitt; Patrick Rossignol; Faiez Zannad. "Eplerenone in patients with myocardial
infarction and “mid-range” ejection fraction: An analysis from the EPHESUS trial". Clinical Cardiology (2019): https://doi.org/10.1002/clc.23261.
10.1002/clc.23261
- Kobayashi M; Voors AA; Girerd N; Billotte M; Anker SD; Cleland JG; Lang CC; et al. "Heart failure etiologies and clinical
factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF.". European journal of internal medicine
(2019): http://europepmc.org/abstract/med/31708361.
10.1016/j.ejim.2019.10.017
- Monzo L; Ferreira JP; Abreu P; Szumski A; Böhm M; McMurray JJV; Pitt B; et al. "Visit-to-visit blood pressure variation and
outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure
and Mild Symptoms trial.". Journal of hypertension (2019): http://europepmc.org/abstract/med/31584516.
10.1097/hjh.0000000000002275
- João Pedro Ferreira; Patrick Rossignol; Faiez Zannad. "Renin-angiotensin-aldosterone system and kidney interactions in heart
failure". Journal of the Renin-Angiotensin-Aldosterone System (2019): https://doi.org/10.1177/1470320319889415.
10.1177/1470320319889415
- Ferreira JP; Rossignol P; Dewan P; Lamiral Z; White WB; Pitt B; McMurray JJV; Zannad F. "Income level and inequality as complement
to geographical differences in cardiovascular trials.". American heart journal (2019): http://europepmc.org/abstract/med/31707330.
10.1016/j.ahj.2019.08.019
- Ferreira JP; Kraus S; Mitchell S; Perel P; Piñeiro D; Chioncel O; Colque R; et al. "World Heart Federation Roadmap for Heart
Failure.". Global heart (2019): http://europepmc.org/abstract/med/31451235.
10.1016/j.gheart.2019.07.004
- Tromp J; Ferreira JP; Janwanishstaporn S; Shah M; Greenberg B; Zannad F; Lam CSP. "Heart failure around the world.". European
journal of heart failure (2019): http://europepmc.org/abstract/med/31419004.
10.1002/ejhf.1585
- Salah K; Stienen S; Moons AHM; Bakx ALM; van Pol PE; Kortz RAM; Ferreira JP; et al. "External Validation of the ELAN-HF Score,
Predicting 6-Month All-Cause Mortality in Patients Hospitalized for Acute Decompensated Heart Failure.". Journal of the
American Heart Association (2019): http://europepmc.org/abstract/med/31296084.
10.1161/jaha.118.010309
- Kobayashi M; Bercker M; Huttin O; Pierre S; Sadoul N; Bozec E; Chouihed T; et al. "Chest X-ray quantification of admission
lung congestion as a prognostic factor in patients admitted for worsening heart failure from the ICALOR cohort study.". International
journal of cardiology (2019): http://europepmc.org/abstract/med/31281047.
10.1016/j.ijcard.2019.06.062
- Stienen S; Rossignol P; Barros A; Girerd N; Pitt B; Zannad F; Ferreira JP. "Determinants of anti-fibrotic response to mineralocorticoid
receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival
Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure
(REMINDER) trials.". Clinical research in cardiology : official journal of the German Cardiac Society (2019): http://europepmc.org/abstract/med/31250134.
10.1007/s00392-019-01500-3
- Mehra MR; Vaduganathan M; Fu M; Ferreira JP; Anker SD; Cleland JGF; Lam CSP; et al. "A comprehensive analysis of the effects
of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus
rhythm: the COMMANDER HF trial". European heart journal (2019): http://europepmc.org/abstract/med/31461239.
10.1093/eurheartj/ehz427
- Ferreira, João Pedro; Pizard, Anne; Machu, Jean-Loup; Bresso, Emmanuel; Rocca, Hans-Peter Brunner-La; Girerd, Nicolas; Leroy,
Céline; et al. "Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS
case–control analyses". Clinical Research in Cardiology 109 1 (2019): 22-33. http://dx.doi.org/10.1007/s00392-019-01480-4.
Publicado • 10.1007/s00392-019-01480-4
- Stienen S; Ferreira JP; Vincent J; Busselen M; Li B; McMurray JJV; Pitt B; et al. "Estimated Long-Term Survival With Eplerenone.".
Journal of the American College of Cardiology (2019): http://europepmc.org/abstract/med/31072582.
10.1016/j.jacc.2019.02.043
- Ferreira JP; Verdonschot J; Collier T; Wang P; Pizard A; Bär C; Björkman J; et al. "Proteomic Bioprofiles and Mechanistic
Pathways of Progression to Heart Failure.". Circulation Heart Failure (2019): http://europepmc.org/abstract/med/31104495.
Publicado • 10.1161/circheartfailure.118.005897
- Stienen S; Ferreira JP; Girerd N; Duarte K; Lamiral Z; McMurray JJV; Pitt B; et al. "Mean BMI, visit-to-visit BMI variability
and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure:
insights from the High-Risk Myocardial Infarction Initiative.". Clinical research in cardiology : official journal of the
German Cardiac Society (2019): http://europepmc.org/abstract/med/30953180.
10.1007/s00392-019-01453-7
- João Pedro Ferreira; Patrick Rossignol; Anne Pizard; Jean-Loup Machu; Timothy Collier; Nicolas Girerd; Anne-Cécile Huby; et
al. "Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure". Heart
105 4 (2019): 307-314. https://doi.org/10.1136/heartjnl-2018-313182.
10.1136/heartjnl-2018-313182
- Zannad F; Ferreira JP; Pitt B. "Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation
issues and future developments.". European heart journal supplements : journal of the European Society of Cardiology
(2019): http://europepmc.org/abstract/med/30837806.
10.1093/eurheartj/suy034
- Ferreira JP; Abreu P; McMurray JJV; van Veldhuisen DJ; Swedberg K; Pocock SJ; Vincent J; et al. "Renal function stratified
dose comparisons of eplerenone versus placebo in the EMPHASIS-HF trial.". European journal of heart failure (2019):
http://europepmc.org/abstract/med/30768732.
10.1002/ejhf.1400
- Januzzi J; Ferreira JP; Böhm M; Kaul S; Wanner C; Brueckmann M; Petrie MC; et al. "Empagliflozin reduces the risk of a broad
spectrum of heart failure outcomes regardless of heart failure status at baseline.". European journal of heart failure
(2019): http://europepmc.org/abstract/med/30767353.
10.1002/ejhf.1419
- Kobayashi M; Watanabe M; Coiro S; Bercker M; Paku Y; Iwasaki Y; Chikamori T; et al. "Mid-term prognostic impact of residual
pulmonary congestion assessed by radiographic scoring in patients admitted for worsening heart failure.". International
journal of cardiology (2019): http://europepmc.org/abstract/med/30770263.
10.1016/j.ijcard.2019.01.091
- Lopez-Sublet M; Girerd N; Bozec E; Machu JL; Ferreira JP; Zannad F; Mourad JJ; Rossignol P. "Nondipping Pattern and Cardiovascular
and Renal Damage in a Population-Based Study (The Stanislas Cohort Study).". American journal of hypertension (2019):
http://europepmc.org/abstract/med/30753257.
10.1093/ajh/hpz020
- Dewan P; Rørth R; Jhund PS; Ferreira JP; Zannad F; Shen L; Køber L; et al. "Income Inequality and Outcomes in Heart Failure:
A Global Between-Country Analysis.". JACC. Heart failure (2019): http://europepmc.org/abstract/med/30738981.
10.1016/j.jchf.2018.11.005
- Zannad, Faiez; Ferreira, João Pedro; Zannad F; Ferreira JP. "Is Sacubitril/Valsartan Antifibrotic?". Journal of the American
College of Cardiology 73 7 (2019): 807-809. http://dx.doi.org/10.1016/j.jacc.2018.11.041.
Publicado • 10.1016/j.jacc.2018.11.041
- Rossignol P; Ferreira JP. "Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients: Mind
the Gap of Biological Monitoring!". JACC. Heart failure (2019): http://europepmc.org/abstract/med/30606485.
10.1016/j.jchf.2018.11.016
- Ferreira JP; Metra M; Anker SD; Dickstein K; Lang CC; Ng L; Samani NJ; et al. "Clinical correlates and outcome associated
with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study.". European
journal of heart failure (2019): http://europepmc.org/abstract/med/30600578.
10.1002/ejhf.1380
- Patrick Rossignol; João Pedro Ferreira. "Extracting Meaning of Tubular Injury Molecules: Implications for Cardiorenal Health".
American Journal of Nephrology (2019): 343-345. https://doi.org/10.1159/000499533.
10.1159/000499533
- João Pedro Ferreira; António Barros; Bertram Pitt; Gilles Montalescot; Esteban Lopez de Sa; Christian W. Hamm; Marcus Flather;
et al. "Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings
from the REMINDER trial". Clinical Research in Cardiology 107 12 (2018): 1192-1195. https://doi.org/10.1007/s00392-018-1373-5.
10.1007/s00392-018-1373-5
- Ferreira JP; Couchoud C; Gregson J; Tiple A; Glowacki F; London G; Agarwal R; et al. "Angiotensin-converting enzyme inhibitors/angiotensin
receptor blockers, ß-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched
longitudinal cohort study.". Nephrology, dialysis, transplantation : official publication of the European Dialysis and
Transplant Association - European Renal Association 34 7 (2018): 1216-1222. http://europepmc.org/abstract/med/30590716.
Publicado • 10.1093/ndt/gfy378
- Kobayashi M; Rossignol P; Ferreira JP; Aragão I; Paku Y; Iwasaki Y; Watanabe M; et al. "Correction to: Prognostic value of
estimated plasma volume in acute heart failure in three cohort studies.". Clinical research in cardiology : official journal
of the German Cardiac Society (2018): http://europepmc.org/abstract/med/30402715.
10.1007/s00392-018-1390-4
- Saraiva FA; Girerd N; Cerqueira RJ; Ferreira JP; Vilas-Boas N; Pinho P; Barros A; et al. "Survival after bilateral internal
mammary artery in coronary artery bypass grafting: Are women at risk?". International journal of cardiology (2018):
http://europepmc.org/abstract/med/30219542.
10.1016/j.ijcard.2018.05.028
- Ferreira JP; Bauters C; Eschalier R; Lamiral Z; Fay R; Huttin O; Girerd N; et al. "Echocardiographic diastolic function evolution
in patients with an anterior Q-wave myocardial infarction: insights from the REVE-2 study.". ESC heart failure (2018):
http://europepmc.org/abstract/med/30460754.
10.1002/ehf2.12359
- Greene SJ; Hernandez AF; Sun JL; Butler J; Armstrong PW; Ezekowitz JA; Zannad F; et al. "Relationship Between Enrolling Country
Income Level and Patient Profile, Protocol Completion, and Trial End Points.". Circulation. Cardiovascular quality and
outcomes (2018): http://europepmc.org/abstract/med/30354576.
10.1161/circoutcomes.118.004783
- Ferreira JP; Metra M; Mordi I; Gregson J; Ter Maaten JM; Tromp J; Anker SD; et al. "Heart failure in the outpatient versus
inpatient setting: findings from the BIOSTAT-CHF study.". European journal of heart failure (2018): http://europepmc.org/abstract/med/30338883.
10.1002/ejhf.1323
- Ferreira JP; Zannad F. "Patient-reported and morbidity-mortality endpoints: can one have the best of both worlds?". European
journal of heart failure (2018): http://europepmc.org/abstract/med/30280452.
10.1002/ejhf.1317
- Kobayashi M; Rossignol P; Ferreira JP; Aragão I; Paku Y; Iwasaki Y; Watanabe M; et al. "Prognostic value of estimated plasma
volume in acute heart failure in three cohort studies.". Clinical research in cardiology : official journal of the German
Cardiac Society (2018): http://europepmc.org/abstract/med/30341579.
10.1007/s00392-018-1385-1
- Rossello, Xavier; Ferreira, João Pedro; McMurray, John JV; Aguilar, David; Pfeffer, Marc A; Pitt, Bertram; Dickstein, Kenneth;
et al. "Editor’s Choice- Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction".
European Heart Journal: Acute Cardiovascular Care 8 3 (2018): 231-241. http://dx.doi.org/10.1177/2048872618803701.
Publicado • 10.1177/2048872618803701
- Rossello X; Ferreira JP; McMurray JJ; Aguilar D; Pfeffer MA; Pitt B; Dickstein K; et al. "Impact of insulin-treated diabetes
on cardiovascular outcomes following high-risk myocardial infarction.". European heart journal. Acute cardiovascular care
(2018): http://europepmc.org/abstract/med/30259764.
10.1177/2048872618803701
- Rossello X; Ariti C; Pocock SJ; Ferreira JP; Girerd N; McMurray JJV; Van Veldhuisen DJ; Pitt B; Zannad F. "Impact of mineralocorticoid
receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction:
an individual patient-level meta-analysis of three randomized-controlled trials". Clinical research in cardiology : official
journal of the German Cardiac Society (2018): http://europepmc.org/abstract/med/30264282.
10.1007/s00392-018-1378-0
- Sharma A; Cooper LB; Fiuzat M; Mentz RJ; Ferreira JP; Butler J; Fitchett D; et al. "Antihyperglycemic Therapies to Treat Patients
With Heart Failure and Diabetes Mellitus". JACC. Heart failure (2018): http://europepmc.org/abstract/med/30098964.
10.1016/j.jchf.2018.05.020
- Ferreira JP; Duarte K; McMurray JJV; Pitt B; van Veldhuisen DJ; Vincent J; Ahmad T; et al. "Data-Driven Approach to Identify
Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response
Patterns". Circulation. Heart failure (2018): http://europepmc.org/abstract/med/29997240.
10.1161/circheartfailure.118.004926
- Chau K; Girerd N; Bozec E; Ferreira JP; Duarte K; Nazare JA; Laville M; et al. "Association between abdominal adiposity and
20-year subsequent aortic stiffness in an initially healthy population-based cohort.". Journal of hypertension (2018):
http://europepmc.org/abstract/med/29878971.
10.1097/hjh.0000000000001796
- Zied Frikha; João Pedro Ferreira; Erwan Bozec; John J.V. McMurray; Bertram Pitt; Kenneth Dickstein; Patrick Rossignol; Faiez
Zannad; Nicolas Girerd. "Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated
by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative)". The American
Journal of Cardiology 121 9 (2018): 1015-1020. https://doi.org/10.1016/j.amjcard.2018.01.012.
10.1016/j.amjcard.2018.01.012
- Rossignol P; Ferreira JP; Zannad F. "Fibrosis mechanistic phenotyping and antifibrotic response determination with biomarkers
in heart failure: one single biomarker may not fit all settings". European journal of heart failure (2018): http://europepmc.org/abstract/med/29851257.
10.1002/ejhf.1214
- João Pedro Ferreira; Patrick Rossignol; Biniyam Demissei; Abhinav Sharma; Nicolas Girerd; Stefan D Anker; John G Cleland;
et al. "Coronary angiography in worsening heart failure: determinants, findings and prognostic implications". Heart
104 7 (2018): 606-613. https://doi.org/10.1136/heartjnl-2017-311750.
10.1136/heartjnl-2017-311750
- Ferreira JP; Duarte K; Pitt B; Dickstein K; McMurray JJV; Zannad F; Rossignol P. "Visit-to-visit blood pressure variation
is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction
and/or heart failure: findings from the EPHESUS and OPTIMAAL trials.". Journal of hypertension (2018): http://europepmc.org/abstract/med/29683884.
10.1097/hjh.0000000000001742
- Chau K; Girerd N; Magnusson M; Lamiral Z; Bozec E; Merckle L; Leosdottir M; et al. "Obesity and metabolic features associated
with long-term developing diastolic dysfunction in an initially healthy population-based cohort.". Clinical research in
cardiology : official journal of the German Cardiac Society (2018): http://europepmc.org/abstract/med/29680861.
10.1007/s00392-018-1259-6
- Ferreira JP; Girerd N; Gregson J; Latar I; Sharma A; Pfeffer MA; McMurray JJV; et al. "Stroke Risk in Patients With Reduced
Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation.". Journal of the American College of Cardiology
(2018): http://europepmc.org/abstract/med/29447733.
10.1016/j.jacc.2017.12.011
- Ferreira JP; Duarte K; Pfeffer MA; McMurray JJV; Pitt B; Dickstein K; Zannad F; Rossignol P; High-Risk Myocardial Infarction
Database Initiative. "Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular
events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk
Myocardial Infarction Database Initiative.". European journal of heart failure (2018): http://europepmc.org/abstract/med/29314455.
10.1002/ejhf.1131
- Ferreira, João. "NT-proBNP-Guided Therapy in Acute Decompensated Heart Failure: The PRIMA II Randomized Controlled Trial.".
Circulation (2017): http://europepmc.org/abstract/med/29242350.
10.1161/circulationaha.117.029882
- Ferreira, João. "Cohort Profile: Rationale and design of the fourth visit of the STANISLAS Cohort: a familial longitudinal
population-based cohort from the Nancy region of France.". International journal of epidemiology (2017): http://europepmc.org/abstract/med/29220499.
10.1093/ije/dyx240
- Ferreira, João; Ferreira, João Pedro; Girerd, Nicolas; Zannad, Faiez. "Interpretation of the ATHENA Trial-Caveats and Future
Directions.". JAMA cardiology 3 1 (2017): 89. http://europepmc.org/abstract/med/29214308.
Publicado • 10.1001/jamacardio.2017.4370
- Ferreira, João. "Practical management of concomitant acute heart failure and worsening renal function in the emergency department.".
European journal of emergency medicine : official journal of the European Society for Emergency Medicine (2017): http://europepmc.org/abstract/med/28984663.
10.1097/mej.0000000000000505
- Ferreira, João. "Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis.". ESC
heart failure (2017): http://europepmc.org/abstract/med/28988439.
10.1002/ehf2.12218
- Ferreira, João. "The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF Subanalysis.". Journal of the American
College of Cardiology (2017): http://europepmc.org/abstract/med/29050560.
10.1016/j.jacc.2017.08.057
- Ferreira, João Pedro; Duarte, Kévin; Montalescot, Gilles; Pitt, Bertram; de Sa, Esteban Lopez; Hamm, Christian W.; Flather,
Marcus; et al. "Effect of eplerenone on extracellular cardiac matrix biomarkers in patients with acute ST-elevation myocardial
infarction without heart failure: insights from the randomized double-blind REMINDER Study". Clinical Research in Cardiology
107 1 (2017): 49-59. http://dx.doi.org/10.1007/s00392-017-1157-3.
Publicado • 10.1007/s00392-017-1157-3
- Ferreira, João. "Individualizing treatment choices in the systolic blood pressure intervention trial.". Journal of hypertension
(2017): http://europepmc.org/abstract/med/28858981.
10.1097/hjh.0000000000001535
- Ferreira JP; Rossignol P; Machu JL; Sharma A; Girerd N; Anker SD; Cleland JG; et al. "Mineralocorticoid receptor antagonist
pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF.". (2017): http://europepmc.org/abstract/med/28580625.
10.1002/ejhf.900
- Jacobs, Lotte; Efremov, Ljupcho; Ferreira, João Pedro; Thijs, Lutgarde; Yang, Wen-Yi; Zhang, Zhen-Yu; Latini, Roberto; et
al. "Risk for Incident Heart Failure: A Subject-Level Meta-Analysis From the Heart “OMics” in AGEing (HOMAGE) Study". Journal
of the American Heart Association 6 5 (2017): http://dx.doi.org/10.1161/jaha.116.005231.
Publicado • 10.1161/jaha.116.005231
- João Pedro Ferreira; Anna Kearney Schwartz; Ghassan Watfa; Lamiral Zohra; Jacques Felblinger; Jean-Marc Boivin; Serge Bracard;
et al. "Memory Alterations and White Matter Hyperintensities in Elderly Patients With Hypertension: The ADELAHYDE-2 Study".
Journal of the American Medical Directors Association (2017): https://doi.org/10.1016%2Fj.jamda.2017.01.008.
10.1016/j.jamda.2017.01.008
- Zannad F; Ferreira JP. "Reply: Cardiopulmonary Exercise Testing Versus 6-Min Walk Test as Clinically Meaningful Endpoints
in HF Trials.". (2017): http://europepmc.org/abstract/med/28449788.
10.1016/j.jacc.2017.01.065
- Rossignol P; Lamiral Z; Frimat L; Girerd N; Duarte K; Ferreira J; Chanliau J; Castin N. "Hyperkalaemia prevalence, recurrence
and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year survey.". (2017): http://europepmc.org/abstract/med/28460113.
10.1093/ndt/gfx053
- Ferreira JP; Mentz RJ; Pizard A; Pitt B; Zannad F. "Tailoring mineralocorticoid receptor antagonist therapy in heart failure
patients: are we moving towards a personalized approach?". (2017): http://europepmc.org/abstract/med/28401618.
10.1002/ejhf.814
- Ferreira, João Pedro; Girerd, Nicolas; Duarte, Kevin; Coiro, Stefano; McMurray, John J. V.; Dargie, Henry J.; Pitt, Bertram;
et al. "Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection
Fraction". Circulation: Heart Failure 10 2 (2017): http://dx.doi.org/10.1161/circheartfailure.116.003500.
Publicado • 10.1161/circheartfailure.116.003500
- João Pedro Ferreira; Nicolas Girerd; Pedro Bettencourt Medeiros; Miguel Bento Ricardo; Tiago Almeida; Alexandre Rola; Faiez
Zannad; Patrick Rossignol; Irene Aragão. "Lack of Diuretic Efficiency (but Not Low Diuresis) Early in An Acutely Decompensated
Heart Failure Episode Is Associated with Increased 180-Day Mortality". Cardiorenal Medicine 7 2 (2017): 137-149. https://doi.org/10.1159/000455903.
10.1159/000455903
- Ferreira JP; Duarte K; Graves TL; Zile MR; Abraham WT; Weaver FA; Lindenfeld J; Zannad F. "Natriuretic Peptides, 6-Min Walk
Test, and Quality-of-Life Questionnaires as Clinically Meaningful Endpoints in HF Trials.". (2016): http://europepmc.org/abstract/med/27978953.
- Ferreira JP; Girerd N; Pannier B; Rossignol P; London GM; João Pedro Ferreira; Nicolas Girerd; et al. "High Pulse-Wave Velocity
Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60.". American Journal of Nephrology
45 1 (2016): 72-81. http://europepmc.org/abstract/med/27898419.
10.1159/000453338
- Ferreira JP; Girerd N; Pellicori P; Duarte K; Girerd S; Pfeffer MA; McMurray JJ; et al. "Renal function estimation and Cockroft-Gault
formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial
infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives.". (2016):
http://europepmc.org/abstract/med/27829460.
- Zannad F; Ferreira JP; Zannad, Faiez; Ferreira, João Pedro. "Oral Anticoagulant Agents in Patients With Atrial Fibrillation
and Heart Failure". JACC: Heart Failure 4 11 (2016): 881-884. http://europepmc.org/abstract/med/27810080.
10.1016/j.jchf.2016.09.002
- Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; et al. "Association of beta-blocker treatment with
mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left
ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.".
(2016): http://europepmc.org/abstract/med/27774703.
10.1002/ejhf.647
- Girerd, Nicolas; Ferreira, João Pedro; Rossignol, Patrick; Zannad, Faiez. "A tentative interpretation of the TOPCAT trial
based on randomized evidence from the brain natriuretic peptide stratum analysis". European Journal of Heart Failure
18 12 (2016): 1411-1414. http://dx.doi.org/10.1002/ejhf.621.
Publicado • 10.1002/ejhf.621
- Pitt B; Pedro Ferreira J; Zannad F. "Mineralocorticoid receptor antagonists in patients with heart failure: current experience
and future perspectives.". (2016): http://europepmc.org/abstract/med/27530337.
- Zannad F; Ferreira JP. "Globalization of heart failure trials: no turning back on this paradigm.". (2016): http://europepmc.org/abstract/med/27469370.
- Ferreira, João Pedro; Girerd, Nicolas; Alshalash, Saleh; Konstam, Marvin A.; Zannad, Faiez; Ferreira JP; Girerd N; et al.
"Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges". European
Heart Journal 37 31 (2016): 2455-2464. http://dx.doi.org/10.1093/eurheartj/ehw213.
Publicado • 10.1093/eurheartj/ehw213
- Ferreira JP; Girerd N; Medeiros PB; Santos M; Carvalho HC; Bettencourt P; Kénizou D; et al. "Spot urine sodium excretion as
prognostic marker in acutely decompensated heart failure: the spironolactone effect.". (2016): http://europepmc.org/abstract/med/26615605.
10.1007/s00392-015-0945-x
- Brembilla-Perrot B; Ferreira JP; Manenti V; Sellal JM; Olivier A; Villemin T; Beurrier D; et al. "Predictors and prognostic
significance of tachycardiomyopathy: insights from a cohort of 1269 patients undergoing atrial flutter ablation.". (2016):
http://europepmc.org/abstract/med/26833591.
10.1002/ejhf.482
- Ferreira JP; Girerd N; Arrigo M; Medeiros PB; Ricardo MB; Almeida T; Rola A; et al. "Enlarging Red Blood Cell Distribution
Width During Hospitalization Identifies a Very High-Risk Subset of Acutely Decompensated Heart Failure Patients and Adds Valuable
Prognostic Information on Top of Hemoconcentration.". Medicine 95 14 (2016): e3307. http://europepmc.org/abstract/med/27057905.
Publicado • 10.1097/MD.0000000000003307
- Ferreira JP; Girerd N; Bozec E; Machu JL; Boivin JM; London GM; Zannad F; Rossignol P. "Intima-Media Thickness Is Linearly
and Continuously Associated With Systolic Blood Pressure in a Population-Based Cohort (STANISLAS Cohort Study).". (2016):
http://europepmc.org/abstract/med/27312804.
10.1161/JAHA.116.003529
- Coiro, Stefano; Pedro Ferreira, João; Ambrosio, Giuseppe; Zannad, Faiez; Girerd, Nicolas; Coiro S; Pedro Ferreira J; et al.
"To the Editor— Diabetes and sudden death: Let’s assess the absolute risk increase rather than the proportional risk from
sudden cardiac death!". Heart Rhythm 12 11 (2015): e138. http://dx.doi.org/10.1016/j.hrthm.2015.08.008.
Publicado • 10.1016/j.hrthm.2015.08.008
- Stienen, Susan; Salah, Khibar; Dickhoff, Cathelijne; Carubelli, Valentina; Metra, Marco; Magrini, Laura; Di Somma, Salvatore;
et al. "N-Terminal Pro–B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute
Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance
of Treatment". Journal of Cardiac Failure 21 11 (2015): 930-934. http://dx.doi.org/10.1016/j.cardfail.2015.07.011.
Acesso aberto • Publicado • 10.1016/j.cardfail.2015.07.011
- Ferreira JP; Coiro S; Girerd N. "A Systematic Assessment of Absolute Treatment Effect.". (2015): http://europepmc.org/abstract/med/26253997.
10.1016/j.amjcard.2015.07.023
- Ferreira JP; Girerd N; Rossignol P; Zannad F. "Geographic differences in heart failure trials.". (2015): http://europepmc.org/abstract/med/26198782.
10.1002/ejhf.326
- Ferreira JP; Santos M. "Heart failure and atrial fibrillation: from basic science to clinical practice.". (2015): http://europepmc.org/abstract/med/25647414.
10.3390/ijms16023133
- Nunes S; Maia J; Ferreira JP; Neves J; Marques I. "Oxygen therapy: a clinical audit in an Internal Medicine Department.".
(2015): http://europepmc.org/abstract/med/25926375.
10.1016/j.rppnen.2014.11.005
- Ferreira JP; Santos M; Almeida S; Marques I; Bettencourt P; Carvalho H. "The role of albuminuria as a non-invasive marker
for congestive acutely decompensated chronic heart failure and the spironolactone effect in elderly Portuguese: a non-randomized
trial.". (2014): http://europepmc.org/abstract/med/24533733.
10.1111/nep.12188
- Ferreira JP; Santos M; Almeida S; Marques I; Bettencourt P; Carvalho H. "Mineralocorticoid receptor antagonism in acutely
decompensated chronic heart failure.". (2014): http://europepmc.org/abstract/med/24070521.
10.1016/j.ejim.2013.08.711
- Silveira, I.; Mota, F.; Ferreira, J.P.; Dias, R.; Leuschner, P.. "Von Meyenburg complex or liver metastasis? case report and
literature review | Complexo de Von Meyenburg ou metástases hepáticas? caso clínico e revisão da literatura". Acta Medica
Portuguesa 27 2 (2014): 271-273. http://www.scopus.com/inward/record.url?eid=2-s2.0-84900011258&partnerID=MN8TOARS.
- João Pedro Ferreira; Mário Santos; Sofia Almeida; Irene Marques; Paulo Bettencourt; Henrique Carvalho. "High-dose spironolactone
changes renin and aldosterone levels in acutely decompensated heart failure". Cor et Vasa 56 6 (2014): e463-e470. http://dx.doi.org/10.1016/j.crvasa.2014.06.004.
10.1016/j.crvasa.2014.06.004
- Silveira I; Mota F; Ferreira JP; Dias R; Leuschner P. "[Von Meyenburg complex or liver metastasis? Case report and literature
review]". Acta Médica Portuguesa (2014): http://europepmc.org/abstract/med/24813499.
Publicado
- Ferreira, João Pedro; Santos, Mário; Oliveira, José Carlos; Marques, Irene; Bettencourt, Paulo; Carvalho, Henrique; Ferreira
JP; et al. "Influence of Spironolactone on Matrix Metalloproteinase-2 in Acute Decompensated Heart Failure". Arquivos Brasileiros
de Cardiologia 104 4 (2014): 308-314. http://dx.doi.org/10.5935/abc.20140205.
Publicado • 10.5935/abc.20140205
- Ferreira, João Pedro; Santos, Mário; Almeida, Sofia; Marques, Irene; Bettencourt, Paulo; Carvalho, Henrique; Ferreira JP;
et al. "High-Sensitivity Troponin T: A Biomarker for Diuretic Response in Decompensated Heart Failure Patients". Cardiology
Research and Practice 2014 (2014): 1-9. http://dx.doi.org/10.1155/2014/269604.
Publicado • 10.1155/2014/269604
- Ferreira, João. "Urinary sodium to potassium ratio: a potential biomarker of mineralocorticoid receptor antagonism in acutely
decompensated heart failure". European Journal of Heart Failure 16 (2014): 67-67.
Publicado
- Ferreira JP; Gomes F; Rodrigues P; Araújo Abreu M; Maia JM; Bettencourt P; Luz A; Torres S; Araújo Correia J. "Left-sided
infective endocarditis: analysis of in-hospital and medium-term outcome and predictors of mortality.". (2013): http://europepmc.org/abstract/med/24209740.
10.1016/j.repc.2012.11.015
- Ferreira JP; Santos M; Almeida S; Marques I; Bettencourt P; Carvalho H. "Tailoring diuretic therapy in acute heart failure:
insight into early diuretic response predictors.". (2013): http://europepmc.org/abstract/med/23839288.
10.1007/s00392-013-0588-8
- Silva, S.V.; Ferreira, J.P.; Carvalho, S.; Seabra, F.; Marinho, A.; Silva SV; Ferreira JP; et al. "Antineutrophil cytoplasmatic
antibody positive systemic vasculitis in a patient treated with propylthiouracil". Acta Reumatologica Portuguesa 38
4 (2013): 302-305. http://www.scopus.com/inward/record.url?eid=2-s2.0-84893511068&partnerID=MN8TOARS.
- Ferreira, J.P.; Silva, S.V.; Rodrigues, P.; Abreu, M.A.; Maia, J.M.; Carvalho, D.; Carvalho, L.. "Stability of blood gases
when refrigerated". New Zealand Journal of Medical Laboratory Science 66 2 (2012): 42-45. http://www.scopus.com/inward/record.url?eid=2-s2.0-84864779892&partnerID=MN8TOARS.
- Ferreira, João Pedro; Almeida, Isabel; Marinho, António; Cerveira, Conceição; Vasconcelos, Carlos. "Anti-Ro52 Antibodies and
Interstitial Lung Disease in Connective Tissue Diseases Excluding Scleroderma". ISRN Rheumatology 2012 (2012): 1-4.
http://dx.doi.org/10.5402/2012/415272.
10.5402/2012/415272
- Ferreira, João. "Are Anti-Ro52 Antibodies Associated with Pulmonary Involvement in Scleroderma?". Journal of Pulmonary
& Respiratory Medicine (2012): http://repositorio.chporto.pt/bitstream/10400.16/1328/1/antiRo52Scleroderma.pdf.
Acesso aberto • Publicado • 10.4172/2161-105X.100011
- Ferreira JP; Abreu MA; Rodrigues P; Carvalho L; Correia JA. "[Meticilin resistant Staphylococcus aureus and liver abscess:
a retrospective analysis of 117 patients].". (2011): http://europepmc.org/abstract/med/22849928.
- Ferreira, J.P.; Abreu, M.A.; Rodrigues, P.; Carvalho, L.; Correia, J.A.. "Meticilin resistant staphylococcus aureus and liver
abscess: A retrospective analysis of 117 patients | Staphylococcus aureus resistente à meticilina e abcesso hepático análise
retrospectiva de 117 casos". Acta Medica Portuguesa 24 SUPPL.2 (2011): 399-406. http://www.scopus.com/inward/record.url?eid=2-s2.0-84863492778&partnerID=MN8TOARS.
- Rodrigues P; Neves M; Ferreira JP; Abreu MA; Almeida F. "Investigating a case of recurrent pleural effusion.". (2011): http://europepmc.org/abstract/med/22937429.
10.1155/2011/695057
- Polónia J; Maldonado J; Ramos R; Bertoquini S; Duro M; Almeida C; Ferreira J; et al. "Estimation of salt intake by urinary
sodium excretion in a Portuguese adult population and its relationship to arterial stiffness.". (2006): http://europepmc.org/abstract/med/17100171.
- Polónia, J.; Maldonado, J.; Ramos, R.; Bertoquini, S.; Duro, M.; Almeida, C.; Ferreira, J.; et al. "Estimation of salt intake
by urinary sodium excretion in a Portuguese adult population and its relationship to arterial stiffness | Determinação do
consumo de sal numa amostra da população Portuguesa adulta pela excreção urinária de sódio. Sua relação com rigidez arterial".
Revista Portuguesa de Cardiologia 25 9 (2006): 801-817. http://www.scopus.com/inward/record.url?eid=2-s2.0-33750448252&partnerID=MN8TOARS.
